Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

United States Securities and Exchange Commission

WASHINGTON, D.C.20549

FORM 10-K

x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the fiscal year ended November 30, 2023

¨ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ___________to ___________

Commission file number 000-5109

Micropac Industries, Inc.

(Exact name of registrant as specified in charter)

Delaware		75-1225149
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
1655 State Highway 66, Garland, TX	75040	972/272-3571
(Address of principal executive offices)	(Zip Code)	(Telephone No.)

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.10 par value per share	MPAD	NONE

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ¨

Accelerated filer ¨

Non-accelerated filer ¨

Smaller reporting company x

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No x

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the fi ling reflect the correction of an error to previously issued financial statements. ¨

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ¨

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of May 27, 2023, representing the last business day of the registrant’s most recently completed second fiscal quarter, was approximately $7,304,856, The number of shares of the registrant’s common stock, $0.10 par value, outstanding as of February 7, 2024, was 2,578,315.

DOCUMENTS INCORPORATED BY REFERENCE

The definitive proxy statement to be filed with the Securities and Exchange Commission relating to the registrant’s Annual Meeting of Shareholders, to be held March 8, 2024, is incorporated by reference in Part III to the extent described therein.

Table of Contents

		Page
Part I

Item 1.	Business	3
Item 1A.	Risk Factors	6
Item 1B.	Unresolved Staff Comments	9
Item 2.	Properties	9
Item 3.	Legal Proceedings	10
Item 4.	Mine Safety Disclosure	10

Part II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	10
Item 6.	[Reserved]	11
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	11
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	15
Item 8.	Financial Statements and Supplementary Data	15
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	29
Item 9A.	Controls and Procedures	29
Item 9B.	Other Information	30

Part III

Item 10.	Directors, Executive Officers and Corporate Governance	30
Item 11.	Executive Compensation	33
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	36
Item 13.	Certain Relationships and Related Transactions, and Director Independence	36
Item 14.	Principal Accountant Fees and Services	36

Part IV

Item 15.	Exhibits, Financial Statement Schedules	37
Item 16.	Form 10K Summary	38

	Signatures	38

PART I

Item 1.

Business

GENERAL

Micropac Industries, Inc. (the “Company”), a Delaware corporation, designs, manufactures and distributes various types of microelectronic circuits including solid state relays and power controllers, optoelectronic components, and sensor and display components and assemblies. The Company’s products are used as components and assemblies in a broad range of military, space, medical and commercial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200^o C) products.

The Company’s facilities are certified and qualified by the Defense Logistics Agency (DLA) to MIL-PRF-38534 (class K-space level) and MIL-PRF-19500 JANS (space level) and are certified to ISO 9001:2015 and AS 9100D. Micropac is a National Aeronautics and Space Administration (NASA) core supplier and is registered to AS9100-Aerospace Industry standard for supplier certification. The Company has Underwriters Laboratories (UL) approval on our industrial power controllers.

The Company’s core technologies are microelectronic and optoelectronic designs to include the packaging and interconnecting of multi-chip microelectronics modules. Other technologies include light emitting and light sensitive materials and products, including light emitting diodes and silicon phototransistors, and electronic integration used in the Company’s optoelectronic components and assemblies.

The Company was started in 1963 as a sole proprietorship. On March 3, 1969, the Company was incorporated under the name of “Micropac Industries, Inc.” in the state of Delaware. The stock was publicly held by 434 shareholders on November 30, 2023.

PRODUCTS AND TECHNOLOGIES

The Company’s products are either custom (being application-specific circuits designed and manufactured to meet the particular requirements of a single customer) or standard proprietary components. Custom-designed components and assemblies accounted for approximately 25% of the Company’s sales for the fiscal year ended November 30, 2023, and were 29% for fiscal 2022. Standard components and assemblies accounted for approximately 75% of the Company’s sales for the fiscal year ended November 30, 2023, and were 71% for fiscal 2022.

The Company provides microelectronics, sensors and displays, and optoelectronics products, to include components and assemblies that offer a wide range of products sold to the industrial, medical, military, aerospace and space markets.

The microelectronic technologies, including custom microcircuits, solid state relays, power operational amplifiers, and regulators accounted for 29% of the Company’s business in 2023 compared to 29% in 2022. Sensors and displays accounted for 44% of the Company’s business and the optocouplers product accounted for 27% of the Company’s business in 2023, compared to 43% and 28% in 2022, respectively.

The Company’s basic products and technologies include:

Custom design hybrid microelectronic circuits

Solid state relays and power controllers

Custom optoelectronic assemblies and components

Optocouplers

Light-emitting diodes

Hall-Effect sensors

Displays

Fiber optic components and assemblies

Power distribution electronics

Radiation tolerant electronics

Micropac’s products are primarily sold to original equipment manufacturers (OEM’s) who serve the following major markets:

Military/Aerospace – aircraft instrumentation, guidance and navigation systems, control circuitry, power supplies, laser positioning

Medical – optoelectronic sensors and electronics

Space – control circuitry, power monitoring and sensing

Industrial – power control equipment and robotics

The Company has two patents. On July 11, 2017, the Company received its patent for the “Power Controller”, which expires on July 10, 2031. On January 6, 2018, the Company received its patent for the “Voltage bus protection and isolation devices”, which expires on January 5, 2032.

The Company has no licenses, franchises, or labor contracts. The Company’s has two trademarks registered with the U.S. Patent and Trademark Office.

Sales of our products internationally are subject to government regulations, including export control regulations of the U.S. Department of State and Department of Commerce. Violation of these regulations by the Company could result in monetary penalties and denial of export privileges. The Company is not aware of any violations of export control regulations or similar applicable government regulations.

Five of the Company’s principal product families require government approval. Further, a significant portion of our business is military and is dependent on maintaining our facility certifications to MIL-PRF-38534 and MIL-PRF-19500. In addition, several customers require the Company maintain AS 9100 certifications. We expect to maintain these certifications and qualifications; however, the loss of any of these certifications would have a significant negative impact on our business.

Government regulations impose certain controls on chemicals used in electronics and semiconductor manufacturing. Micropac has obtained appropriate environmental permits, and routinely monitors and reports the wastewater stream results to the local governing agency. Micropac is classified as a small generator of hazardous waste, and the annual cost of complying with the regulations is minimal.

In 2023, the Company’s investment in technology through research and development, which was expensed, totaled approximately $2,224,000 ($2,191,000 in 2022). The Company’s research and development expenditures were directed primarily toward standard proprietary microelectronic products, including industrial power controllers and DC-DC converters, fiber optic transceivers, high voltage optocouplers and continued product development and improvement associated with the Company’s space level and other high reliability products.

In addition to the Company’s investment in research and development, various customers paid the Company approximately $3,687,000 in non-recurring engineering revenue with $2,522,000 recorded within cost of goods sold associated with the development of custom products for specific applications.

The Company provides a one-year warranty from the date of shipment to the original purchaser. The Company is obligated under this warranty to either replace or repair defective goods or refund the purchase price paid by the buyer.

CUSTOMERS

The Company’s products are marketed throughout the United States and in Western Europe, through a direct technical sales staff, independent representatives, and independent stocking distributors. Approximately 6% of the sales for fiscal year 2023 (4% in 2022) were to international customers. Sales to Western European customers are made by independent representatives under the coordination of the Company’s office in Bremen, Germany.

Sales through the Company’s distribution channels were $10,070,000 in 2023 compared to $10,330,000 in 2022, or 33% and 37% of sales, respectively.

The Company’s major customers include contractors to the United States government. Sales to these customers for the Department of Defense (DOD) and NASA contracts accounted for approximately 74% of the Company’s revenues in 2023 compared to 77% in 2022.

The Company’s major customers are Lockheed Martin, Northrop Grumman, United Technologies, BAE, and Boeing. Two customers accounted for 14% and 10% of the Company’s sales during 2023 and two customers accounted for 18% and 10% of the Company’s sales during 2022.

BACKLOG

At November 30, 2023, the Company had a backlog of unfilled orders totaling approximately $36,370,000 compared to approximately $32,686,000 at November 30, 2022.

New orders for 2023 totaled $34,015,000 compared to $27,961,000 for 2022.

The backlog represents a good mix of the company’s products and technologies with 6% in the commercial market, 4% in the medical market, 83% in the military market, and 7% in the space market on November 30, 2023.

2023 Current Backlog by Major Market
	Military		Space		Medical		Commercial		Total
Domestic Direct	$	17,059	$	295	$	1,522	$	1,130	$	20,006
Domestic Distribution		12,709		1,956		-		672		15,337
International		269		466		-		292		1,027
	$	30,037	$	2,717	$	1,522	$	2,094	$	36,370

2023 Current Backlog by Product Line
Microelectronics	$	19,831
Optoelectronics		4,954
Sensors and Displays		11,585
	$	36,370

HUMAN CAPITAL

Micropac Industries, Inc., is committed to attracting and retaining the brightest and best talent. Therefore, investing, developing, and maintaining human capital is critical to our success.

We are committed to advancing Diversity, Equity, and Inclusion (DE&I) across the entire Company and the future success of the Company relies on our ability to attract and retain a diverse workforce. DE&I are and have long been, critical to our culture and our Company’s success and our performance depends on attracting, developing, motivating, and retaining a highly skilled workforce, including engineering, manufacturing, business development and strategy and management.

At November 30, 2023, the Company had 143 full-time employees (compared to 147 at November 30, 2022), of which 14 were executive and managerial employees, 37 were engineers and quality-control personnel, 17 were clerical and administrative employees, and 75 were production personnel. None of the Company’s employees are covered by collective bargaining agreements.

The Company is an equal opportunity employer. It is the Company’s policy to recruit, hire, train and promote personnel in all job classifications, without regard to race, religion, color, national origin, sex or age. Above and beyond non-discrimination, we are committed to an Affirmative Action Program, dedicated to the hiring, training, and advancement within the Company of minority group members, women, veterans, and handicapped individuals.

Our values are also integral to our commitment to long-term sustainability, with environmental, social and governance (ESG) across our Company. With the construction of our new manufacturing center, discussed below, the Company has included in the design and construction significant improvements in support of our commitment to ESG.

COMPETITION

The Company competes with two or more companies with respect to each of its major products. Some of these competitors are larger and have greater capital resources than the Company. Management believes the Company’s competitive position is favorable with regard to our product reliability and integrity, past performance, customer service and responsiveness, timely delivery and pricing; however, no assurance can be given that the Company can compete successfully in the future.

There are approximately 35 independent manufacturing companies who are certified to supply microcircuits to MIL-PRF-38534 or supply semiconductors to MIL-PRF-19500, in addition to OEM’s, who manufacture hybrid microcircuits for their internal needs. Micropac may compete with all of these for hybrid microcircuit, power management and optoelectronics business. Some of the Company’s primary competitors are TTM Technologies, Cobham Advanced Electronic Solutions, TT Electronics, and Infineon Technologies.

SUPPLY CHAIN

The parts and raw materials for the Company’s products are generally available from more than one source. Except for certain optoelectronic products, the Company does not manufacture the basic parts or materials used in production of its products. From time to time, the Company has experienced difficulty in obtaining certain materials when needed. The Company’s inability to secure materials for any reason could have adverse effects on the Company’s ability to deliver products on a timely basis and could result in loss of customers or sales. However, the Company has not been materially affected by such shortages. The Company uses capacitors, active semiconductor devices (primarily in chip form), hermetic packages, ceramic substrates, resistor inks, conductor pastes, precious metals and other materials in its manufacturing operations. The Company’s delivery commitments to customers allow for adequate lead times for production of the products including lead time for order and receipt from the supply chain.

Some of the Company’s primary suppliers are NTK Technologies, W. L Gore, Hughes Circuits, Semi-Dice and TTI.

Item 1A.

Material Risk Factors

This annual report on Form 10-K contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially. Investors are warned that forward-looking statements involve risks and unknown factors including, but not limited to: our expectations regarding the potential impacts on our operations of the COVID-19 pandemic; our expectations regarding the potential impacts on our supply chain and on our customers of the COVID-19 pandemic; overall changes in governmental spending for military and space programs; customer cancellation or rescheduling of orders, problems affecting delivery of vendor-supplied raw materials and components, unanticipated manufacturing problems and availability of direct labor resources.

The Company disclaims any responsibility to update the forward-looking statements contained herein, except as may be required by law.

Concentration Related Risk Factors

The Company is heavily dependent on a few major customers

The Company’s major customers include contractors to the United States government. Sales to these customers for DOD and NASA contracts accounted for approximately 74% of the Company’s revenues in 2023 compared to 77% in 2022. The Company’s major customers are Lockheed Martin, Northrop Grumman, United Technologies, BAE, and Boeing. Two customers accounted for 14% and 10% of the Company’s sales during 2023 and two customers accounted for 18% and 10% during 2022. The contracts of our customers with the United States government may be subject to renegotiation of profits or termination of contracts or subcontracts at the election of the government, which in turn might materially affect the Company’s sales. The loss of any one of these customers or a significant reduction in their purchases would be likely to adversely affect our business.

Financing Related Risk Factors

We experience pricing pressures from customers for reduction in selling prices

The Company continues to experience pricing pressures from some of its OEM customers. In some cases, the Company’s customers request the review of pricing for possible reduction in selling price on future orders. This requires the Company to improve its productivity and to request similar price reductions from its supply chain. If one or both of the approaches by the Company does not succeed, the Company could be required to reduce the selling price on future orders, reducing the product gross margins and affecting the Company’s net earnings in order to receive future orders from the customer. However, the Company has no agreement that requires a reduction in the selling price on any current customer order. All contracts are firm fixed pricing.

The Company has potential warranty obligations

Inflation and rising costs

The cost to manufacture the Company’s products is influenced by the cost of raw materials and labor. The Company has recently experienced higher costs with increasing cost of labor and cost of raw materials with inflation. The Company may, from time to time, offset these cost increases by increasing the prices of its products on new contracts.

Operations Related Risk Factors

Fabrication efforts may not be successful

The Company produces silicon phototransistors and light-emitting diode die for use in certain military, standard and custom products. Fabrication efforts sometimes may not result in successful results, limiting the availability of these components. Competitors offer commercial level alternatives, and our customers may purchase our competitors’ products if the Company is not able to manufacture the products using these technologies to meet the customer demands.

Component shortages from suppliers could affect ability to manufacture products or delay shipments to customers

The Company relies on suppliers to deliver quality raw materials in a timely and cost-effective manner. Most of the materials and components are generally available from multiple sources; however, from time-to-time vendors do not deliver the product as needed due to manufacturing problems or a decision to discontinue that product. Such interruption of supply or price increases could have a material adverse effect on the Company’s operations; however, the Company is not currently impacted by material shortages.

We must maintain the ability to enhance our products and develop new products for the military, space or aerospace markets

The Company’s base products and technologies generally have long life cycles. The Company’s products are primarily used in military, space or aerospace applications, which also have long life cycles. Our future success may, however, depend in part on our ability to enhance the functionality of our existing products in a timely and cost-effective manner, our ability to continue close working relationships with major customers for the design of their new products, and our ability to develop new products and technologies for existing and emerging markets. We must also continue to make significant investments in research and development efforts in order to meet customer specifications for specially fabricated products. We may not be able to retain or obtain engineers, or other technical support staff, to conduct our research and development efforts as needed. There can be no assurance that the Company will be able to design, develop and market new products and technologies on a timely and cost-effective basis. Failure to respond to our customers’ requirements and to our competitors’ progress in technological changes could have a material adverse effect on the Company’s business.

Regulatory Related Risk Factors

We are significantly affected by government policy

The Company could be adversely affected by changes in laws and regulations made by U.S. and non-U.S. governments and agencies dealing with foreign shipments. Changes in trade agreements or taxes on imports or exports could adversely affect our operations or financial condition.

Sales of our products internationally are subject to government regulations, including export control regulations of the U.S. Department of State and Department of Commerce. Changes in these regulations could adversely affect our business. Violation of these regulations by the Company could result in monetary penalties and denial of export privileges.

The Company is subject to the Foreign Corrupt Practices Act (FCPA), which generally prohibits U.S. companies and their intermediaries from making improper payments to foreign officials for the purpose of obtaining or retaining business. Any violation of the FCPA or similar laws and regulations could result in significant expenses, divert management attention, have a material adverse effect on our business, our financial condition and our results of operations and otherwise have a negative impact on the Company and its reputation.

Reductions or changes in U.S. government spending

The loss or significant reduction of a U.S. government or NASA program in which our major customers participate could adversely affect our business. U.S. government contracts generally are conditioned on the continuing availability of Congressional appropriations. Congress usually appropriates funds for on-going programs on a fiscal year basis even though contract performance may extend over many years. At the beginning of a major program, the contract is often only partially funded, and additional monies are committed only as Congress makes appropriations in future fiscal years. In addition, most U.S. government contracts are subject to modification if funding is changed. Key programs in which our customers participate must compete with other programs for consideration during the federal budgeting and appropriation process, and support and funding for any U.S. government program may be influenced by general economic conditions, political considerations, and other factors. A decline in support and funding for programs in which our customers participate could result in contract terminations, delays in contract awards, failure to extend contracts, cancellation of planned procurements and fewer new business opportunities for our customers. Our business may be adversely affected as a result of changes or reductions in U.S. government or NASA spending.

Market Related Risk Factors

Majority shareholder ability to control the election of the Board of Directors

Micropac Industries, Inc. Vermoegensverwaltungsgesellschaft buergerlichen Rechts, a partnership organized under the laws of Germany in 2007 owns 1,952,577 shares or 75.7% of the Company’s outstanding voting shares. Mr. Robert Hempel, through the partnership, has the ability to control the election of the Company’s Board of Directors and elect individuals who may be more attuned to such majority shareholder’s vision for the Company and not necessarily to those of minority shareholders as to the policies and directions of the Company. However, the ability to control the election of the Board of Directors does not modify the fiduciary duties of the Board of Directors to represent the interests of all shareholders.

There are limited shares for purchase and sale

A small number of shares are available for public purchase and sale. The Company’s reported share price may be subject to extreme fluctuations, or one or a few trades may determine the reported market price, due in part to the small number of shares traded at any time.

General Risk Factors

Impact of COVID-19 on our Business

In March 2020 the World Health Organization declared the spread of the COVID-19 virus a pandemic.

The Company continues to monitor our supply chain and orders from customers for COVID-19 pandemic related changes. We are continuing to serve our customers while taking precautions to provide a safe work environment for our employees and customers. We have been staggering some shifts and otherwise adjusting work schedules to maximize our capacity while adhering to recommended precautions. We have established and implemented a work from home provision where possible.

To date, we have not experienced significant raw material shortages; however, supply-chain disruptions could potentially delay or prevent us from fulfilling customer orders.

We are subject to cybersecurity risks

Cybersecurity risks and attacks continue to grow. Cybersecurity attacks are evolving and not always predictable. Attacks include malicious software, threats to information technology infrastructure, denial-of-service attacks on websites, attempts to gain unauthorized access to data, ransomware attacks, and other breaches. Data breaches can originate with authorized or unauthorized persons. Authorized persons could inadvertently or intentionally release confidential or proprietary information, and recipients could misuse data. Such events could lead to interruption of our operations or business, unauthorized release or use of information, compromise of data, damage to our reputation, damage to our customers or vendors, and increased costs to prevent, respond to or mitigate any events.

Insurance coverage and exposure to substantial claims or liabilities

The Company operates manufacturing facilities in Garland, Texas, and subcontracts portions of the Company’s manufacturing to a contract manufacturer in Juarez, Mexico. These facilities use industrial machines and chemicals that could provide risks of personal injury and/or property damage. There is no assurance that accidents will not occur. If accidents do occur, the Company could be exposed to substantial liability. The Company maintains worker’s compensation insurance and general liability insurance for protection of its employees and for protection of the Company’s assets in Garland, Texas and for equipment and inventory located at the contract manufacturer in Juarez, Mexico. In addition to the basic policies mentioned, the Company maintains an umbrella insurance policy. The Company reviews all insurance coverage on an annual basis, and makes any necessary adjustments based on risk assessment and changes in its business. In the opinion of the Company’s management, and its insurance advisors, the Company is adequately insured; however, the Company’s financial position could be materially affected by claims not covered or exceeding coverage currently carried by the Company.

Environmental regulations

The Company is subject to increasingly stringent environmental laws and regulations, including those relating to air emissions, wastewater discharges, chemical and hazardous waste management and disposal. Some of these environmental laws hold owners or operators of land or businesses liable for their own and for previous owners’ or operators’ releases of hazardous or toxic substances or wastes. Other environmental laws and regulations require that we obtain and comply with environmental permits. To date, costs of complying with environmental requirements have not been material. Future events, including those relating to climate change or greenhouse gas emissions, could require the Company to incur expenses related to installation of pollution control equipment, or investigation and cleanup of contaminated sites. If the Company fails to comply with environmental laws and regulations, the Company could be subject to significant liabilities or be required to curtail or cease its manufacturing activities. Changes in environmental laws or regulations could affect the cost of the Company’s products and make it hard for the Company to be competitive with larger companies.

We may default on our line of credit or construction loan

The Company currently has an existing line of credit and a construction loan with a Texas banking institution. In connection therewith, the Company is obligated to maintain certain minimum financial requirements in order to receive advances therefrom. The Company is currently in compliance with such financial requirements, but there is no guarantee that the Company will remain in compliance. If the Company does not maintain compliance with each of the requirements, its ability to receive advances from the line of credit or construction loan will be impaired.

We may incur product liability claims

The use of the Company’s products in commercial or government applications may subject the Company to product liability claims. Although the Company has not experienced any significant product liability claims, the risk of such claims continues. Product liability claims brought against the Company could have a material adverse effect on the Company’s operating results and financial condition.

Our products may have errors or defects that we find only after deployment

Our products are complex, designed to be incorporated in sophisticated applications, and may contain undetected defects, errors, or failures. Although our products are tested during manufacturing, prior to shipping, they may contain defects that are discovered only after the products are incorporated in customer applications. The occurrence of any defects, errors, or failures could result in installation delays, product returns, termination of contracts with our customers, diversion of our resources, increased service and warranty costs, and other losses to our customers, their end users, or to us. Any of these occurrences could also result in the loss of customers, and could damage our reputation, which could reduce our sales. In addition to the risk of unanticipated warranty or recall expenses, our customer contracts may contain provisions that could cause us to incur penalties, be liable for damages, or incur other expenses, if we experience difficulties with respect to the functionality, deployment, operation, and availability of our products and services.

Item 1B.

Unresolved Staff Comments

None.

Item 2.

Properties

The Company purchased 9.2 acres of land in Garland, Texas in 2017. The Company completed construction of the new 76,000 square feet manufacturing center and corporate office on this property. Additionally, the Company still owns two buildings with approximately 32,200 square feet of office and manufacturing space and is currently in the process of selling one building. The Company considers its facilities adequate for its current level of operations.

The Company also subcontracts some manufacturing to Inmobiliaria San Jose De Ciuddad Juarez S.A. DE C.V., a maquila contract manufacturer in Juarez, Mexico. The Company owns all equipment and inventory with temporary importation into Mexico under the maquila rules of Mexico. The Company does not lease or own any real property in Mexico.

The Company employs a sales team in Bremen, Germany who coordinates sales to Western European customers made by independent representatives. The sales manager maintains an office in a private residence. The Company does not lease or own any real property in Germany, or any other foreign country.

Item 3.

Legal Proceedings

The Company is not involved in any material current or pending legal proceedings.

Item 4.

Mine Safety Disclosure

None.

PART II

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information, Holders and Dividends

On February 7, 2024 there were 434 shareholders of record of the Company’s common stock. The stock of the Company is closely held; and, therefore, certain shareholders have the ability to significantly influence decisions. The Company’s common stock is quoted on the OTC Market Pink Sheets under the symbol “MPAD.OB”. The following sets forth the high and low sell price for each quarter during the last two fiscal years:

	HIGH		LOW
Fiscal Year Ended November 30, 2023	PRICE		PRICE
Fourth Quarter	$	11.98	$	10.00
Third Quarter	$	12.50	$	9.77
Second Quarter	$	13.45	$	11.50
First Quarter	$	14.50	$	12.81

Fiscal Year Ended November 30, 2022
Fourth Quarter	$	14.95	$	12.25
Third Quarter	$	16.40	$	14.19
Second Quarter	$	17.50	$	15.00
First Quarter	$	17.00	$	14.30

The market price of a share of the common stock as of February 1, 2024, the latest practical date, was $12.50.

During the three month period ended November 30, 2023, approximately 15,700 shares of the Company’s common stock were traded in the over-the-counter market at a price range of $10.00 to $11.98 per share. For the two year period ending November 30, 2022, approximately 434,000 shares of the Company’s common stock were traded in the over-the-counter market at prices ranging from a low of $9.77 to a high of $17.50. The Company’s reported share price may be subject to extreme fluctuations, or one or a few trades may determine the reported market price, due in part to the small number of shares traded at any time.

On December 7, 2022, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 11, 2023. The dividend was paid to shareholders on February 10, 2023.

On December 5, 2023, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 10, 2024. The dividend will be paid to shareholders on or about February 9, 2024.

Securities Issued under Equity Compensation Plan

Micropac Industries Inc.’s 2023 Equity Incentive Plan (“Plan”) aims to promote Micropac’s long-term financial success and increase shareholder value by motivating performance through incentive compensation. The Plan provides for discretionary grants of Restricted Stock Units (“RSUs”) to participating employees, consultants, and directors of Micropac and its Related Companies, subject to the terms in the Plan, the RSU Agreement, and Participant’s obligations and restrictions.

Common Stock delivered under the Plan will be issued as Common Stock held in Micropac’s treasury and will not exceed 500,000 shares at all times, there will be reserves for Awards under the Plan an amount of Common Stock equal to the maximum number of Shares, reduced by the number of Shares earlier issued or delivered as a result of this Plan.

The complete text of the Plan was included as an Exhibit A to SCHEDULE 14A filed February 9, 2023.

Purchases of equity securities by the issuer and affiliated purchasers.

None

Item 6.

[Reserved]

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

	Twelve Months Ended
	November 30, 2023			November 30, 2022

Net Sales		100.0	%		100.0	%

Cost of goods sold		64.5	%		55.7	%
Research and Development		7.3	%		7.9	%
Selling, General, and Administrative		26.4	%		27.8	%
Cost & Expenses		98.2	%		91.4	%

Operating Income		1.8	%		8.6	%

Other income, net		0.9	%		4.0	%

Income before Income Taxes		2.7	%		12.6	%

Provision for taxes		0.6	%		2.6	%

Net Income		2.1	%		10.0	%

The Company designs, manufactures and distributes various types of microelectronic circuits including solid state relays and power controllers, optoelectronic components, and sensor and display components and assemblies. The Company’s products are used as components and assemblies in a broad range of military, space, medical and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, and medical devices.

The Company’s facilities are certified and qualified by the Defense Logistics Agency (DLA) to MIL-PRF-38534 (class K-space level) and MIL-PRF-19500 JANS (space level) and are certified to ISO 9001:2008 and AS 9100D. Micropac is a National Aeronautics and Space Administration (NASA) core supplier and is registered to AS9100-Aerospace Industry standard for supplier certification. The Company has Underwriters Laboratories (UL) approval on our industrial power controllers.

The Company’s core technology is microelectronic and optoelectronic designs to include the packaging and interconnecting of multi-chip microelectronics modules. Other technologies include light emitting and light sensitive materials and products, including light-emitting diodes and silicon phototransistors, and electronic integration used in the Company’s optoelectronic components and assemblies.

Company sales totaled $30,639,000 resulting in an increase of $2,854,000 from 2022. The majority of the increase in sales were due to an increase in shipments of various custom products compared to 2022.

At November 30, 2023, the Company had a backlog of unfilled orders totaling approximately $36,370,000 compared to approximately $32,686,000 at November 30, 2022.

New orders for 2023 totaled $34,015,000 compared to $27,961,000 for 2022.

Approximately $10,142,000 of the new orders received in 2023 were delivered to customers in 2023, along with approximately $20,497,000 of the Company’s 2022 backlog of orders at November 30, 2022, resulting in revenue of $30,639,000.

2023 Current Backlog by Major Market
	Military		Space		Medical		Commercial		Total
Domestic Direct	$	17,059	$	295	$	1,522	$	1,130	$	20,006
Domestic Distribution		12,709		1,956		-		672		15,337
International		269		466		-		292		1,027
	$	30,037	$	2,717	$	1,522	$	2,094	$	36,370

2023 Current Backlog by Product Line
Microelectronics	$	19,831
Optoelectronics		4,954
Sensors and Displays		11,585
	$	36,370

Cost of goods sold, as a percentage of net sales, was 64.5% in 2023 and 55.7% in 2022. In actual dollars, cost of sales increased $4,281,000 which was $19,754,000 in 2023 versus $15,473,000 in 2022. Most of the increase in cost of goods sold was an increase in material cost on a custom product for a customer during the engineering and first production builds resulting in lower gross margins. The contract with the customer on the custom product has been completed. In addition, depreciation expense increased associated with the new facility being placed into service.

In 2023, the Company’s investment in technology through research and development, which was expensed, totaled approximately $2,224,000 ($2,191,000 in 2022). The research and development expenditures were associated with continued development of several power management products and fiber optic transceivers. The Company will continue to invest in research and development of these products and other new opportunities.

Selling, general, and administrative expenses totaled 26.4% of net sales in 2023 compared to 27.8% in 2022. In dollars expensed, selling, general and administrative expenses totaled $8,105,000 in 2023 as compared to $7,734,000 in 2022, an increase of $371,000.The majority of the increase was an increase in property tax on the new building and increase in consulting fees.

Other income and net interest income for fiscal 2023 totaled $270,000 compared to $1,112,000 for fiscal 2022.The overall decrease in other income (expense) was attributable to a one-time credit of $920,000 in employee retention credits, which the Company recognized as other income in the third quarter of 2022.

Income before taxes for fiscal 2023 was approximately $826,000, or 2.7% of net sales, compared to $3,499,000, or 12.6% of net sales in fiscal 2022.

Provisions for income tax for fiscal 2023 totaled $194,000 compared $712,000 for fiscal 2022. The Company’s effective income tax rate was 23.5% for the year ended November 30, 2023, and 20.3% for the year ended November 30, 2022.

Net income totaled approximately $632,000 or $0.24 per share in 2023 versus 2022 net income of $2,787,000 or $1.08 per share.

Impact of COVID-19 on our Business

In March 2020 the World Health Organization declared the spread of the COVID-19 virus a pandemic.

To date, we have not experienced significant raw material shortages; however, supply-chain disruptions could potentially delay or prevent us from fulfilling customer orders.

Liquidity and Capital Resources

The Company obtained a commercial real estate construction loan for the construction of a new 76,000 square foot manufacturing center on the 9.2 acres of land in Garland, Texas that the Company has purchased. On March 26, 2021, the Company (acting as borrower) entered into a Construction Loan Agreement (the “loan agreement”) with Frost Bank (“Frost”) (acting as lender). The Construction Loan Agreement provides for a construction loan, in amounts not to exceed a total principal balance of $16,160,000 with an interest rate of (3.40%) per annum.

On May 16, 2023, the Company renewed the Revolving Loan Agreement with Frost through the “Seventh Amendment to Loan Agreement.” (See Exhibit 10.15). The Revolving Loan Agreement provides for revolving credit loans, in amounts not to exceed a total principal balance of $6,000,000 with a rate equal to prime rate with a floor of 3.25%. The Revolving Loan Agreement was originally entered into on January 23, 2013, between the “Company” as borrower and Frost as lender.

Construction Loans. Subject to the terms of the Loan Agreement, Frost will lend to the Company an aggregate amount not to exceed $16,160,000.

Principal and interest shall be due and payable monthly in an amounts determined by Lender required to fully amortize the outstanding principal balance of this Note over a period of twenty-five (25) years, payable on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2023, and continuing regularly thereafter until March 26, 2031, when the entire amount hereof, principal and accrued interest then remaining unpaid, shall be then due and payable; interest being calculated on the unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

The interest rate of (3.40%) per annum includes an Interest-Only Period. Interest only shall be due and payable monthly as it accrues on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2021, and continuing regularly and monthly thereafter until March 26, 2023; interest being calculated on the unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

The loan shall be secured by a “Deed of Trust, Security Agreement – Financing Statement” covering the 9.2-acre tract in Garland, Texas and the improvements made on it.

Revolving Credit Loans. Subject to the terms of the Revolving Loan Agreement, Frost will lend to the Company, on a revolving basis, amounts not to exceed a total principal balance of $6,000,000, minus amounts available and amounts previously disbursed under outstanding revolving letters of credit. Subject to certain terms and conditions, the Company may borrow, repay and reborrow under the Loan Agreement. The loan has a maturity date of April 23, 2025. The loan shall be secured by a Security Agreement dated as of January 23, 2013, and is given by Borrower in favor of Lender with collateral of all personal property.

The interest on the outstanding and unpaid principal balance shall be computed at a per annum rate equal to the lesser of (a) a rate equal to the Prime Rate per annum; provided, however, in no event shall the resulting rate be less than three and one-quarter percent (3.25%).

In addition, the Company continues on-going investigations for the use of cumulative cash for business expansion and improvements, such as operational improvements and new product expansion.

Cash and cash equivalents totaled $10,299,000 as of November 30, 2023 compared to $15,375,000 on November 30, 2022, a decrease of $5,076,000. The decrease in cash and cash equivalents is attributable to $3,196,000 cash used by operations, payment of a cash dividend of $258,000, $275,000 in long term debt, $404,000 in cash for additional manufacturing equipment and $2,156,000 on the new facility, offset by the $1,213,000 proceeds from the construction loan.

In addition to cash on hand, the Company also has the ability to borrow under a loan agreement as discussed above.

Per the loan covenant, the Company must maintain a ratio of Free Cash Flow to Debt Service of not less than 1.20 to 1.00. As of November 30, 2023, the Company is in compliance.

Company management believes it will meet its 2024 capital requirements through the use of cash derived from operations for the year and/or usage of the Company’s cash and cash equivalents. There were no significant outstanding commitments for equipment purchases or improvements at November 30, 2023.

The Company has no significant off-balance sheet arrangements.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We base our estimates on historical experience and on various other assumptions and factors that are believed to be reasonable under the circumstances. Note 2 to the Financial Statements in the Annual Report on Form 10-K for the year ended November 30, 2023, describes the significant accounting policies and methods used in the preparation of the Financial Statements. liabilities. Actual results could differ from these estimates.

The core principle of revenue recognition under accounting principles generally accepted in the Unites States of America (GAAP) is that the Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company’s revenue on the majority of its customer contracts is recognized at a point in time, generally upon shipment of products. The application of GAAP related to the measurement and recognition of revenue requires us to make judgments and estimates. Specifically, the determination of whether revenues related to our revenue contracts should be recognized over time or at a point in time, as these determinations impact the timing and amount of our reported revenues and net income. Other significant judgments include the estimation of the point in the manufacturing process at which we are entitled to receive payment, as well as the progress of the job order to completion to determine the amount of consideration earned for contractual revenue recognized over time.

The allowance for doubtful accounts is based on our assessment of the collectability of specific customer accounts and the aging of the accounts receivable. If there is a deterioration of a major customer’s credit worthiness or actual defaults are higher than our historical experience, our estimates of the recoverability of amounts due us could be adversely affected.

Inventory purchases and commitments are based upon future demand. If there is a sudden and significant decrease in demand for our products or there is a higher risk of inventory obsolescence because of changing customer requirements, we may be required to increase our inventory allowances and our gross margin could be adversely affected.

The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. If we were to determine we would not be able to realize all or part of the deferred tax asset in the future, an adjustment to the deferred tax asset would be necessary which would reduce our net income for that period.

Depreciable and useful lives estimated for property and equipment are based on initial expectations of the period of time these assets will provide benefit. Changes in circumstances related to a change in our business or other factors could result in these assets becoming impaired, which could adversely affect the value of these assets.

New Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which changes the impairment model for most financial assets. The ASU requires the use of an “expected loss” model for instruments measured at amortized cost, in which companies will be required to estimate the lifetime expected credit loss and record an allowance to offset the amortized cost basis, resulting in a net presentation of the amount expected to be collected on the financial asset. The new guidance is effective for fiscal years beginning after December 15, 2022, for Smaller Reporting Companies, including interim periods within those fiscal years and requires a modified-retrospective approach to adoption. The Company believes that adopting ASU 2016-13 will have no material impact on the financial statements and related disclosures.

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

Item 8.

Financial Statements and Supplementary Data

Page No.

16	Report of Independent Registered Public Accounting Firm - Whitley Penn LLP (PCAOB ID 726)

18	Balance Sheets as of November 30, 2023, and 2022

19	Statements of Income for the years ended November 30, 2023, and 2022

20	Statements of Shareholders’ Equity for the years ended November 30, 2023, and 2022

21	Statements of Cash Flows for the years ended November 30, 2023, and 2022

22-29	Notes to Financial Statements as of and for the years ended November 30, 2023, and 2022

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors of

Micropac Industries, Inc.

Opinion on the Financial Statements

We have audited the accompanying balance sheets of Micropac Industries, Inc. (the “Company”) as of November 30, 2023 and 2022, and the related statements of income, shareholders’ equity, and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of November 30, 2023 and 2022, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and
(2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the account or disclosures to which it relates.

Margin Estimates for Long-Term Contracts and Related Revenue Recognition

Critical Audit Matter Description

As disclosed in Note 2 to the financial statements, the Company produces certain products with no alternative use and for which the Company has an enforceable right to payment during the production cycle. For these contracts, the Company recognizes revenue over time as control over these products transfers to the customer. Thus, the Company records contract assets for work in process contracts at the end of each reporting period. The Company uses costs incurred to date as the method for determining progress, and revenue is recognized based on costs incurred to date plus an estimate of margin at completion. The process of estimating final margin involves estimating the costs to complete production of goods and comparing those costs to the total transaction price. These contracts are inherently uncertain in that revenue is fixed while the estimates of costs required to complete these contracts are subject to variability. Due to the technical performance requirements in many of these contracts, changes to cost estimates could occur, resulting in higher or lower margins when the contracts are completed.

We identified revenue associated with work in process contracts recognized over time as a critical audit matter. The process of estimating final margin is subjective in nature that and resulted in a higher degree of audit effort and judgment. Changes in estimates of final margin could have a significant impact on the timing of revenue recognition.

How We Addressed the Matter

We obtained an understanding of the design of internal controls that address the risks of material misstatement relating to recording revenue from contracts with customers where revenue is recognized over time. We evaluated the reasonableness of judgements made and assumptions used by management relating to key estimates which include estimated total costs to complete and estimated final margins. We reviewed executed contracts to understand the contract terms, reperformed management’s process of assigning the appropriate timing of revenue recognition and tested the mathematical accuracy of revenue recognized over time based on costs incurred to date relative to total estimated margin. We tested the accuracy and completeness of the data used in developing key estimates, including materials, labor, and overhead costs. We performed a review of audit evidence from transactions completed after the measurement date related to the final gross margins for comparison to the Company’s initial gross margin estimates.

We evaluated management’s ability to estimate total inputs accurately by comparing actual inputs to management’s historical estimates for contracts that have been fulfilled.

/s/ Whitley Penn LLP

We have served as the Company's auditor since 2016.

Plano, Texas

February 7, 2024

MICROPAC INDUSTRIES, INC.

BALANCE SHEETS

NOVEMBER 30, 2023 AND 2022

(Dollars in thousands except share and per share data)


CURRENT ASSETS	2023			2022

Cash and cash equivalents	$	10,299		$	15,375
Receivables, net of allowance for doubtful accounts of $0 at November 30, 2023 and 2022		8,021			3,644
Other receivable		139			920
Contract assets		307			408
Inventories:
Raw materials and supplies		7,367			6,715
Work in process		4,113			3,573
Total inventories		11,480			10,288
Prepaid expenses and other assets		487			564
Total current assets		30,733			31,199

PROPERTY, PLANT AND EQUIPMENT, at cost:
Land		1,518			1,518
Buildings		21,013			498
Facility improvements		1,126			1,126
Furniture and fixtures		2,068			1,036
Construction in process		181			19,415
Machinery and equipment		10,175			9,952
Total property, plant, and equipment		36,081			33,545
Less accumulated depreciation		(11,982	)		(11,082	)
Net property, plant, and equipment		24,099			22,463
Operating lease right to use asset		-			14
Deferred income taxes, net		475			86
Total assets	$	55,307		$	53,762

LIABILITIES AND SHAREHOLDERS’ EQUITY

CURRENT LIABILITIES:
Accounts payable	$	1,491		$	1,173
Accrued compensation		958			1,086
Deferred revenue		618			1,192
Property taxes		746			560
Income tax		444			149
Short term debt		432			224
Other accrued liabilities		34			47
Total current liabilities		4,723			4,431

Long term debt, net of debt issuance costs		15,316			14,535
Total liabilities		20,039			18,966
Commitments and contingencies

SHAREHOLDERS’ EQUITY
Common stock, $.10 par value, authorized 10,000,000 shares, 3,078,315 issued and 2,578,315 outstanding at November 30, 2023 and 2022		308			308
Additional paid-in-capital		983			885
Treasury stock, 500,000 shares, at cost		(1,250	)		(1,250	)
Retained earnings		35,227			34,853
Total shareholders’ equity		35,268			34,796
Total liabilities and shareholders’ equity	$	55,307		$	53,762

See accompanying notes to financial statements.

MICROPAC INDUSTRIES, INC.

STATEMENTS OF INCOME

FOR THE YEARS ENDED NOVEMBER 30, 2023 AND 2022

(Dollars in thousands except share and per share data)


	2023			2022
NET SALES	$	30,639		$	27,785

COST AND EXPENSES:
Cost of goods sold		19,754			15,473
Research and development		2,224			2,191
Selling, general and administrative expenses		8,105			7,734

Total cost and expenses		30,083			25,398

OPERATING INCOME		556			2,387

Interest income		534			141
Interest expense		(386	)		(1	)
Other income, net		122			972

INCOME BEFORE INCOME TAXES		826			3,499

PROVISION FOR INCOME TAXES
Current		583			814
Deferred		(389	)		(102	)
Total tax expense provision		194			712

NET INCOME	$	632		$	2,787

NET INCOME PER SHARE, BASIC	$	0.24		$	1.08

WEIGHTED AVERAGE OF SHARES, BASIC		2,578,315			2,578,315

NET INCOME PER SHARE, DILUTED	$	0.24		$	1.08

WEIGHTED AVERAGE OF SHARES, DILUTED		2,609,509			2,578,315

DIVIDENDS PER SHARE	$	0.10		$	0.10

See accompanying notes to financial statements.

MICROPAC INDUSTRIES, INC.

STATEMENTS OF SHAREHOLDERS’ EQUITY

FOR THE YEARS ENDED NOVEMBER 30, 2023 AND 2022

(Dollars in thousands)


	Common		Additional		Treasury			Retained
	Stock		paid-in-capital		Stock			Earnings			Total


BALANCE, November 30, 2021	$	308	$	885	$	(1,250	)	$	32,324		$	32,267

Dividend		-		-		-			(258	)		(258	)
Net income		-		-		-			2,787			2,787


BALANCE, November 30, 2022		308		885		(1,250	)		34,853			34,796

Stock-based compensation		-		98		-			-			98
Dividend		-		-		-			(258	)		(258	)
Net income		-		-		-			632			632

BALANCE, November 30, 2023	$	308	$	983	$	(1,250	)	$	35,227		$	35,268

See accompanying notes to financial statements.

MICROPAC INDUSTRIES, INC.

STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED NOVEMBER 30, 2023 AND 2022

(Dollars in thousands)


CASH FLOWS FROM OPERATING ACTIVITIES:	2023			2022
Net income	$	632		$	2,787
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation		925			394
Stock based compensation		98			-
Deferred income tax benefit		(389	)		(102	)
Amortization of debt issuance cost		43			-
Change in right of use of asset		13			53
Changes in certain current assets and liabilities:
(Increase) decrease in accounts receivable		(4,377	)		1,330
Increase in other receivable		781			(920	)
(Increase) decrease in contract assets		101			195
Decrease (increase) in inventories		(1,192	)		(1,604	)
Decrease (increase) in prepaid expenses and other assets		77			(223	)
Increase (decrease) in accounts payable		319			403
Increase (decrease) in accrued compensation		(128)			(209)
Increase (decrease) deferred revenue		(574	)		(66	)
Increase (decrease) in income taxes payable		295			(30	)
Decrease in lease liabilities		(14	)		(53	)
Increase in all other accrued liabilities		194			249

Net cash (used in) provided by operating activities		(3,196	)		2,204

CASH FLOWS FROM INVESTING ACTIVITIES:
Additions to property, plant and equipment		(2,560	)		(13,213	)

Net cash used in investing activities		(2,560	)		(13,213	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash dividend		(258	)		(258	)
Proceeds from long term debt		1,213			11,390
Payments on long term debt		(275	)		-

Net cash provided by financing activities		680			11,132

Net (decrease) increase in cash and cash equivalents		(5,076	)		123

Cash and cash equivalents at beginning of period		15,375			15,252

Cash and cash equivalents at end of period	$	10,299		$	15,375

Supplemental Cash Flow Disclosure:
Cash paid for income taxes	$	312		$	845
Cash paid for interest expense	$	539		$	373
Supplemental Non-Cash Flow Disclosure:
Accrued additions to property, plant and equipment	$	4		$	44

See accompanying notes to financial statements.

MICROPAC INDUSTRIES, INC.

NOTES TO FINANCIAL STATEMENTS

NOVEMBER 30, 2023 AND 2022

BUSINESS DESCRIPTION:

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

Revenue Recognition

The Company's revenue on the majority of its customer contracts is recognized at a point in time, generally upon shipment of products.

To achieve that core principle, the Company applies the following steps:

Identify the contract(s) with a customer.

The Company designs, manufactures and distributes various types of microelectronic circuits, optoelectronics, and sensors and displays. The Company’s products are used as components and assemblies in a broad range of military, space, medical and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200^o C) products.

The Company’s revenues are from purchase orders and/or contracts with customers associated with manufacture of products. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

Identify the performance obligations in the contract.

The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products.

Determine the transaction price.

The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer at a fixed price per unit shipped based on the terms of the contract or purchase order with the customer. To the extent our actual costs vary from the fixed price that was negotiated, we will generate more or less profit or could incur a loss.

Allocate the transaction price to the performance obligations in the contract.

The Company’s transaction price is the fixed price per unit per each delivery upon shipment.

Recognize revenue when (or as) the Company satisfies a performance obligation.

This performance obligation is satisfied when control of the product is transferred to the customer, which occurs upon shipment or delivery. The Company receives purchase orders for products to be delivered over multiple dates that may extend across reporting periods. The Company accounting policy treats shipping and handling activities as a fulfillment cost. The Company invoices for each delivery upon shipment and recognizes revenues at the fixed price for each distinct product delivered when transfer of control has occurred, which is generally upon shipment.

For certain contracts under which the Company produces products with no alternative use and for which the Company has an enforceable right to payment during the production cycle, the Company recognizes revenue for the cost incurred of work in process plus a margin at the end of each period and records a contract asset (unbilled receivable). The majority of these products are shipped weekly and monthly to the customers and the contracts require us to manage and limit the level of work in process to meet the scheduled delivery dates.

In addition, the Company may have a contract or purchase order to provide a non-recurring engineering service to a customer. These contracts are reviewed, and performance obligations are determined and we recognize revenue at the point in time in which each performance obligation is fully satisfied.

Disaggregation of Revenue

The following table summarizes the Company’s net sales by product line.

Schedule of net sales by product line
	Nov. 30, 2023		Nov. 30, 2022
Microelectronics	$	8,855	$	7,998
Optoelectronics		8,265		7,913
Sensors and Displays		13,519		11,874
	$	30,639	$	27,785

Timing of revenue recognition
Recognized at a point in time	$	27,069	$	23,678
Recognized over time		3,570		4,107
Total Revenue	$	30,639	$	27,785

The following table summarizes the Company’s net sales by major market.

Schedule of net sales by major market
2023 Sales by Major Market
	Military		Space		Medical		Commercial		Total
Domestic Direct	$	11,937	$	1,525	$	3,179	$	2,099	$	18,740
Domestic Distribution		7,580		1,357		-		1,133		10,070
International		362		600		-		867		1,829
	$	19,879	$	3,482	$	3,179	$	4,099	$	30,639

2022 Sales by Major Market
		Military		Space		Medical		Commercial		Total
Domestic Direct	$	10,699	$	1,148	$	3,213	$	1,403	$	16,433
Domestic Distribution		7,993		1,508		-		829		10,330
International		233		351		-		438		1,022
	$	18,895	$	3,007	$	3,213	$	2,670	$	27,785

Receivables, net, Contract Assets and Contract Liabilities

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the Consolidated Balance Sheet.

Receivables, net, contract assets and contract liabilities were as follows:


	November 30, 2023		November 30, 2022		December 1, 2021
Receivables, net	$	8,021	$	3,644	$	4,974
Contract assets	$	307	$	408	$	603
Deferred revenue	$	618	$	1,192	$	1,258

Revenue recognized in 2023 that was included in the deferred revenue liability balance at the beginning of the year was $1,169,000.

Contract costs

The Company does not have material incremental costs to obtain a contract in the form of sales commissions or bonuses. The Company incurs other immaterial costs to obtain and fulfill a contract; however, the Company has elected the practical expedient under ASC 340-40-24-4 to recognize all incremental costs to obtain a contract as an expense when incurred if the amortization period is one year or less.

Inventories

Inventories are stated at lower of cost or net realizable value and include material, labor and manufacturing overhead. All inventories are valued using the FIFO (first-in, first-out) method of inventory valuation. The Company determines the need to write inventory down to the lower of cost or net realizable value via an analysis based on the usage of inventory over a three year period and projected usage based on current backlog.

Income Taxes

The Company accounts for income taxes using the asset and liability method. Under this method the Company records deferred income taxes for the temporary differences between the financial reporting basis and the tax basis of assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. The resulting deferred tax liabilities and assets are adjusted to reflect changes in tax law or rates in the period that includes the enactment date.

The Company records a liability for an unrecognized tax benefit for a tax position that is not “more-likely-than-not” to be sustained. The Company did not record any liability for uncertain tax positions as of November 30, 2023, or November 30, 2022.

Property, Plant, and Equipment

Property, plant, and equipment are carried at cost, and depreciation is provided using the straight-line method at rates based upon the following estimated useful lives (in years) of the assets:


Buildings	15-40
Facility improvements	8-15
Machinery and equipment	5-10
Furniture and fixtures	5-8

The Company assesses long-lived assets for impairment in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) ASC 360-10-35, Property, Plant and Equipment – Subsequent Measurement. When events or circumstances indicate that an asset may be impaired, an assessment is performed. The estimated future undiscounted cash flows associated with the asset are compared to the asset’s net book value to determine if a write down to market value less cost to sell is required.

Construction in progress relates to multiple capital projects ongoing during the years ended November 30, 2023, and 2022, including the construction of the new manufacturing facility. Construction in progress also includes interest and fees on debt that are directly related to the financing of the Company’s capital projects.

Repairs and maintenance are expensed as incurred. Improvements which extend the useful lives of property, plant, and equipment are capitalized.

Research and Development Costs

Costs for the design and development of new products are expensed as incurred.

Basic and Diluted Earnings Per Share

Basic and diluted earnings per share are computed based upon the weighted average number of shares outstanding during the year. Diluted earnings per share gives effect to all dilutive potential common shares.

The following is a reconciliation of the number of shares used in the calculation of the basic and diluted earnings per share for the years ended November 30, 2023 and 2022:


	Twelve Months Ended
	November 30, 2023		November 30, 2022

Weighted average of shares, basic		2,578,315		2,578,315
Restricted stock units		31,194		-
Weighted average of shares, diluted		2,609,509		2,578,315

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

NEW ACCOUNTING PRONOUNCEMENTS:

FAIR VALUE MEASUREMENT:

The Company had no financial assets and liabilities measured at fair value on a recurring basis as of November 30, 2023, and 2022. The fair value of financial instruments such as cash and cash equivalents, accounts receivable, and accounts payable approximate their carrying amount based on the short maturity of these instruments.

The Company measures its long-term debt at fair value which approximates book value as the long-term debt bears market rates of interest.

There were no nonfinancial assets measured at fair value on a nonrecurring basis at November 30, 2023, or 2022.

NOTES PAYABLE TO BANKS:

On May 16, 2023, the Company renewed the Revolving Loan Agreement with Frost through the “Sixth Amendment to Loan Agreement.” (See Exhibit 10.13). The Revolving Loan Agreement provides for revolving credit loans, in amounts not to exceed a total principal balance of $6,000,000 with a rate equal to prime rate with a floor of 3.25%. The Revolving Loan Agreement was originally entered into on January 23, 2013, between the Company as borrower and Frost as lender.

Construction Loans. Subject to the terms of the Loan Agreement, Frost will lend to the Company an aggregate amount not to exceed $16,160,000.

The interest rate of (3.40%) per annum including an Interest-Only Period. Interest only shall be due and payable monthly as it accrues on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2021, and continuing regularly and monthly thereafter until March 26, 2023; interest being calculated on the unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

The loan shall be secured by a “Deed of Trust, Security Agreement – Financing Statement” covering the 9.2-acre tract in Garland, Texas and the improvements made on it.

Revolving Credit Loans. Subject to the terms of the Loan Agreement, Frost will lend to the Company, on a revolving basis, amounts not to exceed a total principal balance of $6,000,000, minus amounts available and amounts previously disbursed under outstanding Frost letters of credit. Subject to certain terms and conditions, the Company may borrow, repay and reborrow under the Loan Agreement. The loan has a maturity date of April 23, 2025.

The Company has borrowed $16,160,000 against the construction loan as of November 30, 2023.

Schedule of long-term debt
Debt	2023		2022
Notes payable	$	15,884	$	14,938
Less unamortized debt issuance costs		136		179
Net Debt		15,748		14,759
Less—Current portion		432		224
Total long-term debt	$	15,316	$	14,535

Estimated maturities of our long-term debt over the next 5 years are as follows:

Estimated maturities of long-term debt
	2024		2025		2026		2027		2028		Thereafter		Total
Frost Bank	$	432	$	447	$	463	$	478	$	495	$	13,569	$	15,884

PRODUCT WARRANTIES:

In general, the Company warrants that its products, when delivered, will be free from defects in material workmanship under normal use and service. The obligations are limited to replacing, repairing or giving credit for, at the option of the Company, any products that are returned within one year after the date of shipment. The Company does not provide extended warranties.

The Company reserves for potential warranty costs based on historical warranty claims experience. While management considers the process to be adequate to effectively quantify its exposure to warranty claims based on historical performance, changes in warranty claims on a specific or cumulative basis may require management to adjust its reserve for potential warranty costs.

Warranty expense was approximately $56,000 and $114,000 in 2023 and 2022, respectively.

The following table summarizes product warranty activity recorded during the years ended November 30, 2023, and 2022 recorded in other accrued liabilities.

Schedule of product warranty activity
	2023			2022
Beginning balance	$	25		$	25
Additions for current year provision		56			114
Payments for current year		(56	)		(114	)
Ending balance	$	25		$	25

LEASE COMMITMENTS:

In the first quarter of 2020, the Company entered into a three (3) year lease extension on the property that has been leased on a year to year basis. As a result, we recognized $ 165,000 for operating lease liabilities and right-of-use assets in accordance with ASC 842. The Company had an operating lease expense of $14,000 for 2023 and $55,000 for 2022. The Company used an estimated incremental borrowing rate of 3.25% representative of the rate of interest that the company would have to pay to borrow on the Company’s line of credit. The lease expired in March 2023 and was not renewed.

EMPLOYEE BENEFITS:

The Company sponsors an Employees’ Profit Sharing Plan and Trust (the “Plan”). Pursuant to section 401(k) of the Internal Revenue Code, the Plan is available to substantially all employees of the Company. Employee contributions to the Plan are matched by the Company at amounts up to 6% of the participant’s salary. Contributions made by the Company were expensed and totaled approximately $500,000 in 2023 and $476,000 in 2022. Employees become vested in Company contributions in 20% increments in years two through six of employment. If the employee leaves the Company prior to being fully vested, the unvested portion of the Company contributions are forfeited and such forfeitures are used to lower future Company contributions. The Company does not offer other post-retirement benefits to its employees at this time.

INCOME TAXES:

The income tax provision consisted of the following for the years ended November 30:

Schedule of income tax provision
	2023			2022
Current Provision:
Federal	$	514		$	744
State		69			70
		583			814
Deferred federal tax benefit		(389	)		(102	)
Total	$	194		$	712

The provision for income taxes differs from that computed at the federal statutory corporate tax rate as follows for the years ended November 30,


	2023			2022
Tax at statutory rate	$	177		$	734
State income taxes, net of federal benefit		54			55
Research and Development Tax Credit		(116	)		(156	)
Permanent differences and other		79			79

Income tax provision	$	194		$	712

The components of deferred tax assets and liabilities were as follows at November 30,


	2023			2022
Deferred tax assets (liabilities)
Inventory	$	330		$	265
Capitalized research and development		420			-
Deferred revenue, sales returns and warranty		5			5
Other accrued liabilities		100			83
Depreciation		(380	)		(267	)
Net deferred tax assets	$	475		$	86

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income, and tax-planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are deductible, management believes it is more likely than not that the Company will realize the benefits of these deductible differences.

10.

SIGNIFICANT CUSTOMER INFORMATION:

The Company’s major customers include contractors to the United States government. Sales to these customers for DOD and NASA contracts accounted for approximately 74% of the Company’s revenues in 2023 compared to 77% in 2022. The Company’s major customers are Lockheed Martin, Northrop Grumman, United Technologies, BAE, and Boeing. Two customers accounted for 14% and 10% of the Company’s sales during 2023 and two customers accounted for 18% and 10% of the Company’s sales during 2022. The contracts of our customers with the United States government may be subject to renegotiation of profits or termination of contracts or subcontracts at the election of the government, which would in turn might materially affect the Company’s sales. The loss of any one of these customers or a significant reduction in their purchases would be likely to adversely affect our business.

11.

SHAREHOLDERS’ EQUITY:

On December 7, 2021, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 11, 2022. The dividend was paid to shareholders on February 10, 2022.

12.

STOCK-BASED COMPENSATION:

We have issued restricted stock units ("RSUs") stock-based compensation awards as part of Micropac Industries Inc.’s 2023 Equity Incentive Plan. Our 2023 annual grant of RSUs occurred in the second quarter. The weighted -average grant-date fair value of each unit granted in 2023 was $13.13. All the RSUs granted in 2023 vest over a three-year period.

The following is a summary of our RSUs activity for the years ended November 30, 2023, and November 30, 2022:


	2023				2022
(shares in thousands)	Number		Weighted-		Number		Weighted-
	of		Average		of		Average
	Shares		Grant Date Fair Value		Shares		Grant Date Fair Value

Unvested at beginning of the year		-		-		-		-
Granted		35.7	$	13.13		-		-
Vested		-		-		-		-
Cancelled		4.5	$	13.13		-		-
Unvested at end of the year		31.2	$	13.13		-		-

The following table sets forth the stock-based compensation expense recorded in selling, general and administrative ("SG&A") expense (in thousands):

Schedule of stock-based compensation
For the years ended
November 30, 2023 and November 30, 2022
	2023		2022
Stock-based compensation expense	$	98		-

The following table sets forth the stock-based unvested compensation expense by year to be recognized (in thousands):


	2024		2025		Total
Stock-based unvested compensation expense	$	156	$	156	$	312

13.

EMPLOYEE RETENTION CREDIT UNDER THE CARES ACT

The CARES Act, passed by Congress on March 27, 2020, contained the employee retention credit (ERC), a refundable payroll tax credit to employers that have experienced hardship in their operations due to COVID-19. The CARES Act was amended and extended on December 27, 2020, by the Consolidated Appropriations Act, 2021 (the “CAA”) and in March 2021, the Internal Revenue Code was amended by the American Rescue Plan Act of 2021 to provide new employee retention credit provisions designed to promote employee retention and hiring.

This ERC is a fully refundable tax credit for employers equal to 70 percent of qualified wages that eligible employers pay their employees. This ERC applies to qualified wages paid after December 2020 and before January 1, 2022.

As a result, the Company has determined that it qualified for an approximately $920,000 in employee retention credits during the first quarter of 2021, which the Company recognized as other income and recorded in other receivable for the refund claimed in the third quarter of 2022. The ERC impact was included in the Company’s fiscal year 2021 tax return.

14.

SUBSEQUENT EVENTS:

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s Chief Executive Officer and Chief Financial Officer (the Certifying Officers) are responsible for establishing and maintaining disclosure controls and procedures for the Company. The Certifying Officers have designed such disclosure controls and procedures to ensure that material information is made known to them, particularly during the period in which this report was prepared. The Certifying Officers have evaluated the effectiveness of the Company's disclosure controls and procedures (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e) (the Rules) under the Securities Exchange Act of 1934 (or Exchange Act)) and determined that as of November 30, 2023, the Company's disclosure controls and procedures were effective.

Management’s Annual Report on Internal Control Over Financial Reporting

Management of Micropac is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in the Securities Exchange Act Rule 13a-15(f). Under the supervision and with the participation of the Company’s management, including the Chief Executive Officer (principal executive officer) and the Chief Financial Officer (principal financial officer), the Company’s management conducted an evaluation of the effectiveness of its internal control over financial reporting as of November 30, 2023, as required by the Securities Exchange Act of 1934 Rule13a-15(c). In making this assessment, the Company’s management used the criteria set forth in the framework in “Internal Control – Integrated Framework” (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on the evaluation conducted under the framework in “Internal Control – Integrated Framework” (2013), management concluded that the Company’s internal control over financial reporting was effective as of November 30, 2023.

During our most recent fiscal quarter, there has not occurred any change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

This annual report does not include an attestation report of our registered independent public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered independent public accounting firm pursuant to rules of the Securities and Exchange Commission that permit us to provide only management’s report in this annual report.

Item 9B.

Other Information

None.

PART III

In accordance with General Instruction G(3) of Form 10-K, the information required by this Part III is incorporated by reference to Micropac Industries, Inc.’s definitive proxy statement relating to its 2024 Annual Meeting of Stockholders, as set forth below. The 2024 Proxy Statement will be filed with the Securities and Exchange Commission on or about February 7, 2024.

Item 10.

Directors, Executive Officers and Corporate Governance

Name	Age	Position with the Company	Director Since

Mark King	69	CEO, President and
		Member of Audit Committee
		and Chairman of the Board	October 2005

Christine B. Dittrich	71	Director and
		Member of Audit Committee	October 2015

Gerald Tobey	70	Director and
		Member of Audit Committee	June 2017

Donald Robinson	58	Director and
		Member of Audit Committee	December 2019

Shaunna Black	69	Director and
		Member of Audit Committee	December 2019

Robert Hempel	66	Director and	September 2023
		Member of Audit Committee

Patrick S. Cefalu	66	CFO, Executive Vice President	N/A

Mr. King is the current President and Chief Executive of the Company. Prior to November 2002, Mr. King was the President and Chief Operating Officer of Lucas Benning Power Electronics. Mr. King joined the Company in November of 2002, and was elected Chief Executive Officer, President and Director in October 2005.

Ms. Dittrich was an Executive Vice President of Raytheon Systems Company and the General Manager of the Sensor and Electronic Systems segment. Before working for Raytheon, Ms. Dittrich was a Senior Vice President of Texas Instruments (TI) Systems Group, a Malcolm Baldrige Quality Award winner, and the General Manager of the Electronic Systems Division. Her prior assignments include TI Systems Group Vice President and Engineering Manager, Software Engineering Director for the defense business, and Senior Member of Technical Staff. She has had senior executive responsibility for product engineering efforts that involve large scale software and hardware development and integration. Ms. Dittrich provided consulting services with a focus on business strategy and operational performance to various technology companies after leaving Raytheon. She became a Visiting Scientist at the Carnegie Mellon University Software Engineering Institute (SEI), a Federally Funded Research and Development Center and chaired the SEI Board of Advisors for over 10 years. She was a Fellow of the Cutter Business Technical Council and a senior consultant for Cutter Consortium. In addition, she has held membership positions on the Army Science Board, the Department of Defense Software Best Practices - Airlie Software Council and other advisory boards.

Mr. Tobey was a Vice President of Business Development at Raytheon Missile Systems Company retiring in 2016 following a 38-year career in the defense, aerospace, and civil security sectors. He also served as Vice President of International Business Development for both Raytheon's Missile Systems and Network Centric Systems businesses. Until 1997, when Texas Instruments' Defense Systems and Electronics Group was acquired by Raytheon, Mr. Tobey served as that company's Vice President of International Business Development and Managing Director of Texas Instruments UK, Ltd. (a wholly owned TI subsidiary). During Mr. Tobey's career, he has served in various business creation and capture, strategy, program and manufacturing management positions both in the U.S. and abroad. Mr. Tobey holds a Bachelor of Science and a Master of Business Administration degree from Utah State University. He is a graduate of the U.S. Defense Department's Defense Acquisition University and has completed Executive Study at the Anderson School of Management at UCLA.

Mr. Robinson is an executive leader and investor with deep experience in corporate strategy, structuring and executing successful complex corporate initiatives, manufacturing, and mergers and acquisitions. As a partner-level consultant, Mr. Robinson has led engagements in strategy development and M&A integration on transactions ranging from $100M to over $1B in value. His industry experience includes time as an Industrial Engineer with Texas Instruments’ Defense Systems Group and as an executive over industrial engineering, safety and quality systems with Decibel Products, a telecom and electronics manufacturer which grew into Allen Telecom. He served on the Chicago and North Texas chapter boards of the National Association of Corporate Directors (NACD), a national organization focused on providing information and education to corporate directors. Mr. Robinson served as a Business Leadership Center Instructor at the SMU Cox School of Business in Dallas, TX and is a two-time recipient of the Teaching Excellence Award. He holds an MBA from the University of Dallas and a B.S. in Industrial Engineering from Texas A&M University.

Ms. Shaunna Black is President of Shaunna Black and Associates. Ms. Black advises companies on global operations, provides experienced executive talent, and coaches leadership teams. The focus of her company is start-ups, business turnarounds and growth, strategy, organization and systems design, and leadership development. Ms. Black is an innovative and highly accomplished operations/manufacturing executive, who enables leaders to rapidly solve complicated problems. She has managed operations internationally in 25 countries. Ms. Black’s methodology delivers extraordinary performance utilizing the power of diverse, multi-generational teams, creating high performance cultures and metrics-driven systems. She has expertise in leadership and team development, technical and systems design, and production methodology in the technology, industrial, manufacturing and hospitality sectors. Her executive career has provided significant experience in strategy, global operations, technology, risk management and sustainability. Ms. Black has served on Audit, Governance, Safety/Risk and M&A Committees. Her industry experience includes Texas Instruments Vice President, (24 years) Dallas/Fort Worth Area including Vice President, Worldwide Facilities - responsible for the design, construction and operation of TI facilities, environmental, safety and health programs, global real estate, worldwide security, and TI's sustainability strategy; Vice President, Dallas Fabrication - Manager for semiconductor manufacturing in one of TI's premier analog wafer fabrication facilities; and Vice President, Worldwide Facilities and Worldwide Environmental, Safety and Health.

Mr. Robert Hempel has served as the (Managing Director) of Hanseatische Waren-Gesellschaft MBH & Co., KG, Bremen, Germany since 1994.

Mr. Cefalu has over 44 years of experience in management, manufacturing and financial operations in a variety of industries. Mr. Cefalu has been the Chief Financial Officer and Executive Vice President of the Company since September 2001.

Board Meetings and Committees

The Board of Directors held five (5) board meetings during the year ended November 2023. Directors received a fee of $1,500 (other than Mr. King) for each meeting attended during the year ended November 2023. In addition, the Board agreed to pay an annual retainer of $10,000 to Mr. Donald Robinson, Ms. Christine Dittrich, Ms. Shaunna Black and Mr. Gerald Tobey.

The Audit Committee held four (4) meetings during the year ended November 30, 2023. Members of the Audit Committee received a fee of $750 for each meeting attended during the year ended November 2023. Mr. King did not receive any payments for attending meetings of the Audit Committee.

Director Compensation 2023
	Director		Audit Committee		Other fees		Total Fees
Shaunna Black	$	17,500	$	3,000		-	$	20,500
Donald Robinson	$	17,500	$	3,000		-	$	20,500
Christine Dittrich	$	17,500	$	3,000		-	$	20,500
Gerald Tobey	$	17,500	$	3,000		-	$	20,500

Mr. King does not receive any additional compensation for serving as a Director and as a member of the Audit Committee.

Audit Committee

The Board of Directors formed an Audit Committee on May 13, 2002. The members of the Audit Committee operate pursuant to a charter developed by the Board of Directors. The Board has determined that all Audit Committee members qualify as an “audit committee financial expert” for purposes of the rules and regulations of the SEC and that each of these members is sufficiently proficient in reading and understanding our financial statements to serve on the Audit Committee.

With the exception of Mr. King and Mr. Robert Hempel, members of the Audit Committee are considered independent members under the Securities and Exchange Act rules and regulations.

The Audit Committee has reviewed with management and the independent auditors the quality and adequacy of the Company's significant accounting policies. The Audit Committee has considered and reviewed with the independent auditors their audit plans, the scope of the audit, and the identification of audit risks. The Audit Committee has reviewed and discussed the audited financial statements with management and has discussed such financial statements with the independent auditors.

The Audit Committee has received the written disclosures and the report from the independent accountant required by the applicable requirements of the Public Company Accounting Oversight Board (United States) regarding the independent accountant’s communications with the Audit Committee concerning independence and has discussed with the independent accountants the independent accountant’s independence. Based upon the review and discussions referred to above, the Audit Committee recommended to the Board of Directors that the audited financial statements be included in the Company’s annual report on Form 10-K for the fiscal year ended November 30, 2023, for filing with the Securities and Exchange Commission.

Management has the responsibility for the preparation and integrity of the Company's financial statements and the independent registered public accounting firm have the responsibility for the audit of those statements. It is not the duty of the Audit Committee to conduct audits to determine that the Company’s financial statements are complete and accurate and are in accordance with accounting principles generally accepted in the United States. In giving its recommendations, the Audit Committee considered (a) management's representation that such financial statements have been prepared with integrity and objectivity and in conformity with accounting principles generally accepted in the United States of America, and (b) the report of the Company’s independent auditors with respect to such financial

statements.

Nominating, Compensation and Corporate Governance

The Board of Directors does not have a nominating, compensation committee or corporate governance committee or committees performing similar functions.

The Directors of the Company are responsible for developing and recommending corporate governance guidelines, identifying qualified individuals to become directors, recommending selected nominees to serve on the Board, and overseeing the evaluation of the Board.

In addition, the independent Directors are responsible for considering and recommending the compensation arrangements for senior management. As part of its other responsibilities, they provide general oversight of our compensation structure, and, if deemed, necessary, retains and approves compensation consultants and other compensation experts. Other specific duties and responsibilities of reviewing the performance of executive officers; reviewing and approving objectives relevant to executive officer compensation; recommending incentive compensation plans; and recommending compensation policies and practices for service on our Board of Directors.

Board Leadership Structure

Our Board of Directors does not have a policy on whether the roles of Chief Executive Officer and Chairman of the Board of Directors should be separate and, if they are to be separate, whether the Chairman of the Board should be selected from the non-employee directors or be an employee. Our Board of Directors believes that it should be free to make a choice from time to time in any manner that is in the best interest of us and our stockholders.

The Board of Directors believes that Mr. King’s service as both Chief Executive Officer and Chairman of the Board is in the best interest of us and our stockholders. Mr. King possesses detailed and in-depth knowledge of the issues, opportunities and challenges we face and is thus best positioned to develop agendas, to ensure that the Board’s time and attention are focused on the most critical matters. His combined role enables decisive leadership, ensures clear accountability, and enhances our ability to communicate our message and strategy clearly and consistently to our stockholders, employees, and customers and suppliers.

Our Board of Directors believes that the independent directors provide effective oversight of management.

Board of Directors’ Role in the Oversight of Risk Management

The Board of Directors has designated the Audit Committee to take the lead in overseeing risk management at the Board of Directors level. Accordingly, the Audit Committee schedules time for periodic review of risk management, in addition to its other duties. In this role, the Audit Committee receives reports from management, independent registered public accounting firm, outside legal counsel, and other advisors, and strives to generate serious and thoughtful attention to our risk management process and system, the nature of the material risks we face, and the adequacy of our policies and procedures designed to respond to and mitigate these risks.

In addition to the formal compliance program, our Board of Directors encourage management to promote a corporate culture that understands risk management and incorporates it into our overall corporate strategy and day-to-day business operations.

Employee, Officer and Director Hedging

None

Section 16(a) Beneficial Owner Reporting Compliance

Section 16(a) of the Exchange Act requires the Company's directors, executive officers, and 10% stockholders to file reports of ownership and reports of change in ownership of the Company's equity securities with the Securities and Exchange Commission. Directors, executive officers, and 10% stockholders are required to furnish the Company with copies of all Section16(a) forms they file. Based on information provided by such persons and a review of the copies of such reports furnished, the Company believes that during the fiscal year ended November 30, 2023, the Company's directors, executive officers, and 10% stockholders filed on a timely basis all reports required by Section 16(a) of the Exchange Act.

Code of Ethics

The Company has adopted a code of ethics that applies to the Company’s principal executive officer and principal financial officer. In addition, the Company has a code of conduct for all employees, officers and directors of the Company.

Item 11.

Executive Compensation

The information set forth in the 2024 Proxy Statement under the heading “Management Remuneration and Transactions” is incorporated herein.

The following table shows as of November 30, 2023, all cash compensation paid to, or accrued and vested for the account of Mr. Mark King, President and Chief Executive Officer and Mr. Patrick Cefalu, Vice President and Chief Financial Officer. Mr. King and Mr. Cefalu received no non-cash compensation during 2023.

Annual Compensation

									All Other
Name and Principal Position	Year		Annual Salary		Bonus		Stock Grant		Compensation (a)		Total
Mark King,		2023	$	322,032	$	23,981	$	28,328	$	44,950	$	419,291
President and		2022	$	309,936	$	39,500	$	0	$	42,696	$	392,132
Chief Executive Officer ⁽¹⁾		2021	$	301,924	$	13,400	$	0	$	42,672	$	357,996

Patrick Cefalu,		2023	$	200,397	$	23,981	$	18,374	$	39,579	$	284,354
Vice President and		2022	$	192,856	$	39,500	$	0	$	34,809	$	267,165
Chief Financial Officer ⁽²⁾		2021	$	187,873	$	13,400	$	0	$	32,918	$	234,191

(a)

Reflects amounts contributed by Micropac Industries, Inc., under Micropac’s 401(k) profit sharing plan; unused vacation pays; life insurance premiums paid; and reimbursement for medical expenses under Micropac’s Family Medical Reimbursement Plan.

(1) Effective November 2005, Mr. King’s existing employment agreement was revised to provide that Mr. King would serve as the Company’s President and Chief Executive Officer, and a member on the Board of Directors and Audit Committee at a base salary of $186,400 for a term of three (3) years. In December 2005, the Company and Mr. King amended his employment agreement to increase his annual base salary to $225,000. In June 2009, the Company and Mr. King amended his employment agreement to increase his annual base salary to $247,104 for renewable terms of three (3) years with annual increases based on consumer price index with additional increases to be determined by the Board of Directors. The June 2009 amendment also provides under certain events, either the Company or Mr. King can terminate the agreement upon a payment to Mr. King of 18- or 36-months’ salary as severance payments.

(2) Effective February 2004, Mr. Cefalu entered into an employment agreement that Mr. Cefalu would serve as Executive Vice President and Chief Financial Officer for a term of two (2) years. On April 6, 2023, the employment agreement was amended to extend the term for three (3) years and the remaining terms and conditions of the Employment Agreement shall remain if full force and effect.

The Board of Directors reviews and approves the Company’s annual bonus payment’s structure. In 2023 Mr. King and Mr. Cefalu received a bonus payment of $23,981 in December 2022.

Amount included in all other compensation relating to employee benefit plans

The Company maintains a Family Medical Reimbursement Plan for the benefit of its executive officers and their dependents. The Plan is funded through a group insurance policy issued by an independent carrier and provides for reimbursement of 100% of all bona fide medical and dental expenses that are not covered by other medical insurance plans capped at an annual family maximum. During the fiscal year ended November 30, 2023, the Company paid $15,682 in premiums each for Mr. King and Mr. Cefalu which amounts are included in the "All Other Compensation" column shown in the preceding remuneration table.

In July 1984, the Company adopted a Salary Reduction Plan pursuant to Section 401(k) of the Internal Revenue Code. The Plan's benefits are available to all Company employees who are at least 18 years of age and have completed at least six months of service to the Company as of the beginning of a Plan year. Plan participants may elect to defer up to 15% of their total compensation as their contributions, subject to the maximum allowed by the Internal Revenue code 401(k), and the Company matches their contributions up to a maximum of 6% of their total compensation. A participant's benefits vest to the extent of 20% after two years of eligible service and become fully vested at the end of six years. During the fiscal year ended November 30, 2023, the Company made contributions to the Plan for Mr. King in the amount of $18,300 and for Mr. Cefalu in the amount of $13,457 which amount is included in the "All Other Compensation" column shown in the preceding remuneration table.

Employment agreements of the Company’s officers provide that they may elect to carry over any unused vacation time to subsequent periods or elect to be paid for such unused vacation time. Mr. King and Mr. Cefalu did not receive any unused vacation pay in 2023.

During the fiscal year ended November 30, 2023, the Company paid life insurance premiums for the benefit of Mr. King and Mr. Cefalu valued at $10,968 and $10,440, respectively.

PAY VERSUS PERFORMANCE

The following table shows information about the relationship between compensation actually paid for our principal executive officer (PEO) and our non-PEO named executive officers (NEO) and certain financial performance of the Company for the fiscal years ending November 30, 2023 and November 30, 2022.

Year	Summary Compensation Table Total for PEO	Compensation Actually Paid to PEO	Average Summary Compensation Table Total for non-PEO Named Executive Officers	Average Compensation Actually Paid to non- PEO Named Executive Officers	Value of Initial Fixed $100 Investment Based On Total Shareholder Return	Net Income (Loss)
	a	b	c	d	e
2023	419,291	390,963	284,354	265,980	(24.4)	632,000
2022	392,132	392,132	267,165	267,165	(14.0)	2,787,000

The dollar amounts reported are the amounts of total compensation reported for our PEO, Mark King, in the Summary Compensation Table for fiscal years 2023 and 2022.

The dollar amounts reported represent the amount of “compensation actually paid”, as computed in accordance with SEC rules. The dollar amounts reported are the amounts of total compensation reported for Mr. King

The dollar amounts reported are the average of the total compensation reported for our NEO, other than our PEO, Patrick Cefalu who served as Chief Financial Officer for fiscal years 2023 and 2022.

Total shareholder return is calculated as the difference between the price of the Company’s common stock at the end of each fiscal year, represented by the closing trading price as of that date, compared to the price of the Company’s common stock at the beginning of the measurement period, represented by the closing trading price as of the last day of the Company’s 2021 fiscal year plus dividends that were declared or paid during either of the fiscal years presented.

Grant Awards at Fiscal Year-End

	Micropac Industries Inc.’s 2023 Equity Incentive Plan
	Grant	Number	Number of	Actual	Actual	Projected	Projected
	Date	of Shares	Vested Shares	Fiscal 2022	Fiscal 2023	Fiscal 2024	Fiscal 2025
	RSUs
Mark King	12/1/2022	10,355	2,158	-	28,328	45,325	45,312
Patrick Cefalu	12/1/2022	6,718	1,399	-	18,374	29,398	29,411

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table shows the number and percentage of shares of the Company's common stock beneficially owned (a) by each person known by the Company to own 5% or more of the outstanding common stock, (b) by each director and nominee, and (c) by all present officers and directors as a group.

Name and Address	Number of Shares	Percent
of Beneficial Owner⁽¹⁾	Beneficially Owned	of Class⁽¹⁾

Robert Hempel^{(2) (3)}	1,952,577	75.7%

Shaunna Black ⁽³⁾	0	0%

Patrick Cefalu	0	0%

Christine Dittrich ⁽³⁾	0	0%

Mark King ⁽³⁾	17,000	Less than 0.7%

Donald Robinson ⁽³⁾	0	0%

Gerald Tobey ⁽³⁾	0	0%

All officers and directors	1,969,577	76.4%
as a group (7 Persons)

_______________________

⁽¹⁾

Calculated on the basis of the 2,578,315 outstanding shares. There are no options, warrants, or convertible securities outstanding. The address of each person listed is 1655 State Hwy 66, Garland, Texas 75040.

⁽²⁾

Mr. Hempel controls Micropac Industries, Inc. Vermoegensverwaltungsgesellschaft buergerlichen Rechts, which owns the enumerated shares. Micropac Industries, Inc. Vermoegensverwaltungsgesellschaft buergerlichen Rechts is a beneficiary of an Ancillary Agreement entered into in March 1987. The Ancillary Agreement primarily obligates the Company to register Micropac Industries, Inc. Vermoegensverwaltungsgesellschaft buergerlichen Rechts’s stock and allows Micropac Industries, Inc. Vermoegensverwaltungsgesellschaft buergerlichen Rechts to participate in any sale of stock by the Company.

⁽³⁾

A director of the Company. Each incumbent director has been nominated for re-election at the Annual Meeting.

Item 13.

Certain Relationships and Related Transactions, and Director Independence

None.

Item 14.

Principal Accountant Fees and Services

Whitley Penn LLP was selected as the Company’s independent registered public accounting firm in 2016 and has been responsible for the Company's financial audit for the fiscal years ended November 30, 2016, through November 30, 2023.

Management anticipates that a representative from Whitley Penn LLP will be present at the Annual Meeting and will be given the opportunity to make a statement if he or she desires to do so. It is also anticipated that such representative will be available to respond to appropriate questions from stockholders.

AUDIT FEES

The fees for professional services rendered for the audit of our annual financial statements for each of the fiscal years ended November 30, 2023, and November 30, 2022, and the reviews of the financial statements included in our Quarterly Reports on Form 10-Q during those periods were $154,000 and $145,000, respectively.

TAX FEES

Whitley Penn LLP fees for tax return preparation services were $29,500 in 2023, and $29,500 in 2022, respectively.

ALL OTHER FEES

Whitley Penn LLP fees for audit of the Company’s 401K plan was $12,360 in 2023 and $11,000 2022, respectively.

The Audit Committee requests that the Principal Accounting Firm provide the committee with the anticipated charges of all accounting and tax related services to be performed in advance of performing such services. The Audit Committee approves all services in advance of the performance of such services.

Part IV

Item 15.

Exhibits, Financial Statement Schedules

(a)	Exhibits

	31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

	31.2	Certification of Chief Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

	32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002.

	32.2	Certification of Chief Accounting Officer pursuant to 18 U. S. C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002.

	3.1	Bylaws – In the form of Exhibit 3.1 to the Form 8-K filed March 3, 2011 which is incorporated herein.

	4.1	Certificate of Incorporation – In the form of Exhibit 4.1 to the Form S-8 filed August 15, 2001, which is incorporated herein.

	10.1	Loan Agreement dated as of January 23, 2013, by and among Frost Bank and Micropac Industries, Inc. which is filed as Exhibit 10.1 to the Form 8K filed January 29, 2013, which is incorporated by reference herein.

	10.4	Employment Agreement with Patrick Cefalu dated April 6, 2020 – In the form attached as Exhibit 10.4 to the Form 10KSB filed August 23, 2004, which is incorporated herein.

	10.7	Code of Ethics – In the form attached as Exhibit 10.7 to the Form 10KSB filed August 23, 2005 which is incorporated herein.

	10.11	Restated and Amended Employment Agreement with Mark W. King dated June 1, 2009 – In the form attached as Exhibit 10.11 to the Form 10K filed February 10, 2021, which is incorporated herein.

	10.13	“Sixth Amendment to Loan Agreement” dated March 26, 2021, between Micropac Industries, Inc. as borrower and Frost Bank attached as Exhibit 10.13 to Form 8K filed March 30, 2021, which is incorporated herein.

	10.14	“Construction Loan Agreement dated March 26, 2021, between Micropac Industries, Inc. as borrower and Frost Bank attached as Exhibit 10.14 to Form 8K filed March 30, 2021 which is incorporated herein.

	10.15	Amended Employment Agreement with Patrick Cefalu dated April 6, 2023 - In the form attached as Exhibit 10.15 to the Form 10Q filed May 27, 2023, which is incorporated herein.

	10.16	“Seventh Amendment to Loan Agreement” dated May 16, 2023, between Micropac Industries, Inc. as borrower and Frost Bank- In the form attached as Exhibit 10.15 to the Form 10Q filed May 27, 2023, which is incorporated herein.

Item 16.

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MICROPAC INDUSTRIES, INC.




	By:	/s/ Mark King
		Mark King
		President and Chief Executive Officer
		(Principal Executive Officer)


	By:	/s/ Patrick Cefalu
		Patrick Cefalu
		Executive Vice President
		and Chief Financial Officer
		(Principal Accounting Officer)

Dated: February 7, 2024

Pursuant to the requirements of the Securities and Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on February 7, 2024.

/s/ Mark King	/s/ Robert Hempel
Mark King, Director	Robert Hempel, Director




/s/ Donald Robinson	/s/ Gerald Tobey
Donald Robinson, Director	Gerald Tobey, Director




/s/ Christine Dittrich	/s/ Shaunna Black
Christine Dittrich, Director	Shaunna Black, Director

DIRECTORS AND OFFICERS

NOVEMBER 30, 2023

MARK KING

President and Chief Executive Officer

Chairman of the Board

Micropac Industries, Inc.

ROBERT HEMPEL

Managing Director

Hanseatishe Waren Handelsgesellschaft MBH & Co. KG, Bremen, Germany

DONALD ROBINSON

Managing Partner

Metre22, Inc

CHRISTINE DITTRICH

Retired

GERALD TOBEY

Retired

SHAUNNA BLACK

Retired

PATRICK CEFALU

Executive Vice President

Chief Financial Officer

Micropac Industries, Inc.

LEGAL COUNSEL	TRANSFER AGENT & REGISTRAR
Whitaker Chalk Swindle & Schwartz PLLC	Securities Transfer
Fort Worth, Texas	Plano, Texas

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark King, certify that:

I have reviewed this annual report of Micropac Industries, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: February 7, 2024	/s/ Mark King
	Mark King
	Chief Executive Officer
	(Principal Executive Officer)

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Patrick S. Cefalu, certify that:

I have reviewed this annual report of Micropac Industries, Inc.;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: February 7, 2024	/s/ Patrick Cefalu
	Patrick S. Cefalu
	Executive Vice President and Chief Financial Officer (Principal Accounting Officer)

EXHIBIT 32.1

CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Micropac Industries, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Annual Report on Form 10-K for the period ended November 30, 2023 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 7, 2024	/s/ Mark King
	Mark King
	Chief Executive Officer
	(Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EXHIBIT 32.2

CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 7, 2024	/s/ Patrick Cefalu
	Patrick S. Cefalu
	Executive Vice President
	and Chief Financial Officer
	(Principal Accounting Officer)

Cover - USD ($)	12 Months Ended
Cover - USD ($)	Nov. 30, 2023	Feb. 07, 2024	May 27, 2023
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Nov. 30, 2023
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--11-30
Entity File Number	000-5109
Entity Registrant Name	Micropac Industries, Inc.
Entity Central Index Key	0000065759
Entity Tax Identification Number	75-1225149
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	1655 State Highway 66
Entity Address, City or Town	Garland
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75040
City Area Code	972
Local Phone Number	272-3571
Title of 12(b) Security	Common Stock, $0.10 par value per share
Trading Symbol	MPAD
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 7,304,856
Entity Common Stock, Shares Outstanding		2,578,315
Documents Incorporated by Reference [Text Block]	The definitive proxy statement to be filed with the Securities and Exchange Commission relating to the registrant’s Annual Meeting of Shareholders, to be held March 8, 2024, is incorporated by reference in Part III to the extent described therein.
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Auditor Firm ID	726
Auditor Name	Whitley Penn LLP
Auditor Location	Plano, Texas

BALANCE SHEETS - USD ($) $ in Thousands	Nov. 30, 2023	Nov. 30, 2022
CURRENT ASSETS
Cash and cash equivalents	$ 10,299	$ 15,375
Receivables, net of allowance for doubtful accounts of $0 at November 30, 2023 and 2022	8,021	3,644
Other receivable	139	920
Contract assets	307	408
Inventories:
Raw materials and supplies	7,367	6,715
Work in process	4,113	3,573
Total inventories	11,480	10,288
Prepaid expenses and other assets	487	564
Total current assets	30,733	31,199
PROPERTY, PLANT AND EQUIPMENT, at cost:
Land	1,518	1,518
Buildings	21,013	498
Facility improvements	1,126	1,126
Furniture and fixtures	2,068	1,036
Construction in process	181	19,415
Machinery and equipment	10,175	9,952
Total property, plant, and equipment	36,081	33,545
Less accumulated depreciation	(11,982)	(11,082)
Net property, plant, and equipment	24,099	22,463
Operating lease right to use asset		14
Deferred income taxes, net	475	86
Total assets	55,307	53,762
CURRENT LIABILITIES:
Accounts payable	1,491	1,173
Accrued compensation	958	1,086
Deferred revenue	618	1,192
Property taxes	746	560
Income tax	444	149
Short term debt	432	224
Other accrued liabilities	34	47
Total current liabilities	4,723	4,431
Long term debt, net of debt issuance costs	15,316	14,535
Total liabilities	20,039	18,966
SHAREHOLDERS’ EQUITY
Common stock, $.10 par value, authorized 10,000,000 shares, 3,078,315 issued and 2,578,315 outstanding at November 30, 2023 and 2022	308	308
Additional paid-in-capital	983	885
Treasury stock, 500,000 shares, at cost	(1,250)	(1,250)
Retained earnings	35,227	34,853
Total shareholders’ equity	35,268	34,796
Total liabilities and shareholders’ equity	$ 55,307	$ 53,762

BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Nov. 30, 2023	Nov. 30, 2022
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 0	$ 0
Common stock, par value per share	$ 0.10	$ 0.10
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	3,078,315	3,078,315
Common stock, shares outstanding	2,578,315	2,578,315
Treasury stock, shares	500,000	500,000

STATEMENTS OF INCOME - USD ($) $ in Thousands	12 Months Ended
STATEMENTS OF INCOME - USD ($) $ in Thousands	Nov. 30, 2023	Nov. 30, 2022
Income Statement [Abstract]
NET SALES	$ 30,639	$ 27,785
COST AND EXPENSES:
Cost of goods sold	19,754	15,473
Research and development	2,224	2,191
Selling, general and administrative expenses	8,105	7,734
Total cost and expenses	30,083	25,398
OPERATING INCOME	556	2,387
Interest income	534	141
Interest expense	(386)	(1)
Other income, net	122	972
INCOME BEFORE INCOME TAXES	826	3,499
PROVISION FOR INCOME TAXES
Current	583	814
Deferred	(389)	(102)
Total tax expense provision	194	712
NET INCOME	$ 632	$ 2,787
NET INCOME PER SHARE, BASIC	$ 0.24	$ 1.08
WEIGHTED AVERAGE OF SHARES, BASIC	2,578,315	2,578,315
NET INCOME PER SHARE, DILUTED	$ 0.24	$ 1.08
WEIGHTED AVERAGE OF SHARES, DILUTED	2,609,509	2,578,315
DIVIDENDS PER SHARE	$ 0.10	$ 0.10

STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stocks [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Nov. 30, 2021	$ 308	$ 885	$ (1,250)	$ 32,324	$ 32,267
Dividend				(258)	(258)
Net income				2,787	2,787
Ending balance, value at Nov. 30, 2022	308	885	(1,250)	34,853	34,796
Stock-based compensation		98			98
Dividend				(258)	(258)
Net income				632	632
Ending balance, value at Nov. 30, 2023	$ 308	$ 983	$ (1,250)	$ 35,227	$ 35,268

STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	Nov. 30, 2023	Nov. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 632	$ 2,787
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation	925	394
Stock based compensation	98
Deferred income tax benefit	(389)	(102)
Amortization of debt issuance cost	43
Change in right of use of asset	13	53
Changes in certain current assets and liabilities:
(Increase) decrease in accounts receivable	(4,377)	1,330
Increase in other receivable	781	(920)
(Increase) decrease in contract assets	101	195
Decrease (increase) in inventories	(1,192)	(1,604)
Decrease (increase) in prepaid expenses and other assets	77	(223)
Increase (decrease) in accounts payable	319	403
Increase (decrease) in accrued compensation	(128)	(209)
Increase (decrease) deferred revenue	(574)	(66)
Increase (decrease) in income taxes payable	295	(30)
Decrease in lease liabilities	(14)	(53)
Increase in all other accrued liabilities	194	249
Net cash (used in) provided by operating activities	(3,196)	2,204
CASH FLOWS FROM INVESTING ACTIVITIES:
Additions to property, plant and equipment	(2,560)	(13,213)
Net cash used in investing activities	(2,560)	(13,213)
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash dividend	(258)	(258)
Proceeds from long term debt	1,213	11,390
Payments on long term debt	(275)
Net cash provided by financing activities	680	11,132
Net (decrease) increase in cash and cash equivalents	(5,076)	123
Cash and cash equivalents at beginning of period	15,375	15,252
Cash and cash equivalents at end of period	10,299	15,375
Supplemental Cash Flow Disclosure:
Cash paid for income taxes	312	845
Cash paid for interest expense	539	373
Supplemental Non-Cash Flow Disclosure:
Accrued additions to property, plant and equipment	$ 4	$ 44

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Nov. 30, 2023	Nov. 30, 2022
Pay vs Performance Disclosure [Table]
Net Income (Loss) Attributable to Parent	$ 632	$ 2,787

Insider Trading Arrangements

12 Months Ended

Nov. 30, 2023

Insider Trading Arrangements [Line Items]

Material Terms of Trading Arrangement

Item 9B.

Other Information

None.

Rule 10b5-1 Arrangement Adopted

false

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

BUSINESS DESCRIPTION

12 Months Ended

Nov. 30, 2023

Accounting Policies [Abstract]

BUSINESS DESCRIPTION

BUSINESS DESCRIPTION:

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

12 Months Ended

Nov. 30, 2023

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

Revenue Recognition

The Company's revenue on the majority of its customer contracts is recognized at a point in time, generally upon shipment of products.

To achieve that core principle, the Company applies the following steps:

Identify the contract(s) with a customer.

Identify the performance obligations in the contract.

The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products.

Determine the transaction price.

Allocate the transaction price to the performance obligations in the contract.

The Company’s transaction price is the fixed price per unit per each delivery upon shipment.

Recognize revenue when (or as) the Company satisfies a performance obligation.

Disaggregation of Revenue

The following table summarizes the Company’s net sales by product line.

Schedule of net sales by product line
	Nov. 30, 2023		Nov. 30, 2022
Microelectronics	$	8,855	$	7,998
Optoelectronics		8,265		7,913
Sensors and Displays		13,519		11,874
	$	30,639	$	27,785

Timing of revenue recognition
Recognized at a point in time	$	27,069	$	23,678
Recognized over time		3,570		4,107
Total Revenue	$	30,639	$	27,785

The following table summarizes the Company’s net sales by major market.

Schedule of net sales by major market
2023 Sales by Major Market
	Military		Space		Medical		Commercial		Total
Domestic Direct	$	11,937	$	1,525	$	3,179	$	2,099	$	18,740
Domestic Distribution		7,580		1,357		-		1,133		10,070
International		362		600		-		867		1,829
	$	19,879	$	3,482	$	3,179	$	4,099	$	30,639

2022 Sales by Major Market
		Military		Space		Medical		Commercial		Total
Domestic Direct	$	10,699	$	1,148	$	3,213	$	1,403	$	16,433
Domestic Distribution		7,993		1,508		-		829		10,330
International		233		351		-		438		1,022
	$	18,895	$	3,007	$	3,213	$	2,670	$	27,785

Receivables, net, Contract Assets and Contract Liabilities

Receivables, net, contract assets and contract liabilities were as follows:


	November 30, 2023		November 30, 2022		December 1, 2021
Receivables, net	$	8,021	$	3,644	$	4,974
Contract assets	$	307	$	408	$	603
Deferred revenue	$	618	$	1,192	$	1,258

Revenue recognized in 2023 that was included in the deferred revenue liability balance at the beginning of the year was $1,169,000.

Contract costs

Inventories

Income Taxes

Property, Plant, and Equipment

Property, plant, and equipment are carried at cost, and depreciation is provided using the straight-line method at rates based upon the following estimated useful lives (in years) of the assets:


Buildings	15-40
Facility improvements	8-15
Machinery and equipment	5-10
Furniture and fixtures	5-8

Repairs and maintenance are expensed as incurred. Improvements which extend the useful lives of property, plant, and equipment are capitalized.

Research and Development Costs

Costs for the design and development of new products are expensed as incurred.

Basic and Diluted Earnings Per Share

The following is a reconciliation of the number of shares used in the calculation of the basic and diluted earnings per share for the years ended November 30, 2023 and 2022:


	Twelve Months Ended
	November 30, 2023		November 30, 2022

Weighted average of shares, basic		2,578,315		2,578,315
Restricted stock units		31,194		-
Weighted average of shares, diluted		2,609,509		2,578,315

Use of Estimates

NEW ACCOUNTING PRONOUNCEMENTS:

12 Months Ended

Nov. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NEW ACCOUNTING PRONOUNCEMENTS:

NEW ACCOUNTING PRONOUNCEMENTS:

FAIR VALUE MEASUREMENT:

12 Months Ended

Nov. 30, 2023

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENT:

FAIR VALUE MEASUREMENT:

The Company measures its long-term debt at fair value which approximates book value as the long-term debt bears market rates of interest.

There were no nonfinancial assets measured at fair value on a nonrecurring basis at November 30, 2023, or 2022.

NOTES PAYABLE TO BANKS:

12 Months Ended

Nov. 30, 2023

Debt Disclosure [Abstract]

NOTES PAYABLE TO BANKS:

NOTES PAYABLE TO BANKS:

Construction Loans. Subject to the terms of the Loan Agreement, Frost will lend to the Company an aggregate amount not to exceed $16,160,000.

The loan shall be secured by a “Deed of Trust, Security Agreement – Financing Statement” covering the 9.2-acre tract in Garland, Texas and the improvements made on it.

The Company has borrowed $16,160,000 against the construction loan as of November 30, 2023.

Schedule of long-term debt
Debt	2023		2022
Notes payable	$	15,884	$	14,938
Less unamortized debt issuance costs		136		179
Net Debt		15,748		14,759
Less—Current portion		432		224
Total long-term debt	$	15,316	$	14,535

Estimated maturities of our long-term debt over the next 5 years are as follows:

Estimated maturities of long-term debt
	2024		2025		2026		2027		2028		Thereafter		Total
Frost Bank	$	432	$	447	$	463	$	478	$	495	$	13,569	$	15,884

PRODUCT WARRANTIES:

12 Months Ended

Nov. 30, 2023

Guarantees and Product Warranties [Abstract]

PRODUCT WARRANTIES:

PRODUCT WARRANTIES:

Warranty expense was approximately $56,000 and $114,000 in 2023 and 2022, respectively.

The following table summarizes product warranty activity recorded during the years ended November 30, 2023, and 2022 recorded in other accrued liabilities.

Schedule of product warranty activity
	2023			2022
Beginning balance	$	25		$	25
Additions for current year provision		56			114
Payments for current year		(56	)		(114	)
Ending balance	$	25		$	25

LEASE COMMITMENTS:

12 Months Ended

Nov. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

LEASE COMMITMENTS:

LEASE COMMITMENTS:

EMPLOYEE BENEFITS:

12 Months Ended

Nov. 30, 2023

Retirement Benefits [Abstract]

EMPLOYEE BENEFITS:

EMPLOYEE BENEFITS:

INCOME TAXES:

12 Months Ended

Nov. 30, 2023

Income Tax Disclosure [Abstract]

INCOME TAXES:

INCOME TAXES:

The income tax provision consisted of the following for the years ended November 30:

Schedule of income tax provision
	2023			2022
Current Provision:
Federal	$	514		$	744
State		69			70
		583			814
Deferred federal tax benefit		(389	)		(102	)
Total	$	194		$	712

The provision for income taxes differs from that computed at the federal statutory corporate tax rate as follows for the years ended November 30,


	2023			2022
Tax at statutory rate	$	177		$	734
State income taxes, net of federal benefit		54			55
Research and Development Tax Credit		(116	)		(156	)
Permanent differences and other		79			79

Income tax provision	$	194		$	712

The components of deferred tax assets and liabilities were as follows at November 30,


	2023			2022
Deferred tax assets (liabilities)
Inventory	$	330		$	265
Capitalized research and development		420			-
Deferred revenue, sales returns and warranty		5			5
Other accrued liabilities		100			83
Depreciation		(380	)		(267	)
Net deferred tax assets	$	475		$	86

SIGNIFICANT CUSTOMER INFORMATION

12 Months Ended

Nov. 30, 2023

Significant Customer Information

SIGNIFICANT CUSTOMER INFORMATION

10.

SIGNIFICANT CUSTOMER INFORMATION:

The Company’s major customers include contractors to the United States government. Sales to these customers for DOD and NASA contracts accounted for approximately 74% of the Company’s revenues in 2023 compared to 77% in 2022. The Company’s major customers are Lockheed Martin, Northrop Grumman, United Technologies, BAE, and Boeing. Two customers accounted for 14% and 10% of the Company’s sales during 2023 and two customers accounted for 18% and 10% of the Company’s sales during 2022. The contracts of our customers with the United States government may be subject to renegotiation of profits or termination of contracts or subcontracts at the election of the government, which would in turn might materially affect the Company’s sales. The loss of any one of these customers or a significant reduction in their purchases would be likely to adversely affect our business.

SHAREHOLDERS’ EQUITY:

12 Months Ended

Nov. 30, 2023

Equity [Abstract]

SHAREHOLDERS’ EQUITY:

11.

SHAREHOLDERS’ EQUITY:

STOCK-BASED COMPENSATION:

12 Months Ended

Nov. 30, 2023

Stock-based Compensation

STOCK-BASED COMPENSATION:

12.

STOCK-BASED COMPENSATION:

The following is a summary of our RSUs activity for the years ended November 30, 2023, and November 30, 2022:


	2023				2022
(shares in thousands)	Number		Weighted-		Number		Weighted-
	of		Average		of		Average
	Shares		Grant Date Fair Value		Shares		Grant Date Fair Value

Unvested at beginning of the year		-		-		-		-
Granted		35.7	$	13.13		-		-
Vested		-		-		-		-
Cancelled		4.5	$	13.13		-		-
Unvested at end of the year		31.2	$	13.13		-		-

The following table sets forth the stock-based compensation expense recorded in selling, general and administrative ("SG&A") expense (in thousands):

Schedule of stock-based compensation
For the years ended
November 30, 2023 and November 30, 2022
	2023		2022
Stock-based compensation expense	$	98		-

The following table sets forth the stock-based unvested compensation expense by year to be recognized (in thousands):


	2024		2025		Total
Stock-based unvested compensation expense	$	156	$	156	$	312

EMPLOYEE RETENTION CREDIT UNDER THE CARES ACT

12 Months Ended

Nov. 30, 2023

Employee Retention Credit Under Cares Act

EMPLOYEE RETENTION CREDIT UNDER THE CARES ACT

13.

EMPLOYEE RETENTION CREDIT UNDER THE CARES ACT

SUBSEQUENT EVENTS:

12 Months Ended

Nov. 30, 2023

Subsequent Events [Abstract]

SUBSEQUENT EVENTS:

14.

SUBSEQUENT EVENTS:

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: (Policies)

12 Months Ended

Nov. 30, 2023

Accounting Policies [Abstract]

Revenue Recognition

Revenue Recognition

The Company's revenue on the majority of its customer contracts is recognized at a point in time, generally upon shipment of products.

To achieve that core principle, the Company applies the following steps:

Identify the contract(s) with a customer.

Identify the performance obligations in the contract.

The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products.

Determine the transaction price.

Allocate the transaction price to the performance obligations in the contract.

The Company’s transaction price is the fixed price per unit per each delivery upon shipment.

Recognize revenue when (or as) the Company satisfies a performance obligation.

Disaggregation of Revenue

Disaggregation of Revenue

The following table summarizes the Company’s net sales by product line.

Schedule of net sales by product line
	Nov. 30, 2023		Nov. 30, 2022
Microelectronics	$	8,855	$	7,998
Optoelectronics		8,265		7,913
Sensors and Displays		13,519		11,874
	$	30,639	$	27,785

Timing of revenue recognition
Recognized at a point in time	$	27,069	$	23,678
Recognized over time		3,570		4,107
Total Revenue	$	30,639	$	27,785

The following table summarizes the Company’s net sales by major market.

Schedule of net sales by major market
2023 Sales by Major Market
	Military		Space		Medical		Commercial		Total
Domestic Direct	$	11,937	$	1,525	$	3,179	$	2,099	$	18,740
Domestic Distribution		7,580		1,357		-		1,133		10,070
International		362		600		-		867		1,829
	$	19,879	$	3,482	$	3,179	$	4,099	$	30,639

2022 Sales by Major Market
		Military		Space		Medical		Commercial		Total
Domestic Direct	$	10,699	$	1,148	$	3,213	$	1,403	$	16,433
Domestic Distribution		7,993		1,508		-		829		10,330
International		233		351		-		438		1,022
	$	18,895	$	3,007	$	3,213	$	2,670	$	27,785

Receivables, net, Contract Assets and Contract Liabilities

Receivables, net, Contract Assets and Contract Liabilities

Receivables, net, contract assets and contract liabilities were as follows:


	November 30, 2023		November 30, 2022		December 1, 2021
Receivables, net	$	8,021	$	3,644	$	4,974
Contract assets	$	307	$	408	$	603
Deferred revenue	$	618	$	1,192	$	1,258

Revenue recognized in 2023 that was included in the deferred revenue liability balance at the beginning of the year was $1,169,000.

Contract costs

Contract costs

Inventories

Inventories

Income Taxes

Income Taxes

Property, Plant, and Equipment

Property, Plant, and Equipment

Property, plant, and equipment are carried at cost, and depreciation is provided using the straight-line method at rates based upon the following estimated useful lives (in years) of the assets:


Buildings	15-40
Facility improvements	8-15
Machinery and equipment	5-10
Furniture and fixtures	5-8

Repairs and maintenance are expensed as incurred. Improvements which extend the useful lives of property, plant, and equipment are capitalized.

Research and Development Costs

Research and Development Costs

Costs for the design and development of new products are expensed as incurred.

Basic and Diluted Earnings Per Share

Basic and Diluted Earnings Per Share

The following is a reconciliation of the number of shares used in the calculation of the basic and diluted earnings per share for the years ended November 30, 2023 and 2022:


	Twelve Months Ended
	November 30, 2023		November 30, 2022

Weighted average of shares, basic		2,578,315		2,578,315
Restricted stock units		31,194		-
Weighted average of shares, diluted		2,609,509		2,578,315

Use of Estimates

Use of Estimates

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: (Tables)

12 Months Ended

Nov. 30, 2023

Accounting Policies [Abstract]

Schedule of net sales by product line

Schedule of net sales by product line
	Nov. 30, 2023		Nov. 30, 2022
Microelectronics	$	8,855	$	7,998
Optoelectronics		8,265		7,913
Sensors and Displays		13,519		11,874
	$	30,639	$	27,785

Timing of revenue recognition
Recognized at a point in time	$	27,069	$	23,678
Recognized over time		3,570		4,107
Total Revenue	$	30,639	$	27,785

Schedule of net sales by major market

Schedule of net sales by major market
2023 Sales by Major Market
	Military		Space		Medical		Commercial		Total
Domestic Direct	$	11,937	$	1,525	$	3,179	$	2,099	$	18,740
Domestic Distribution		7,580		1,357		-		1,133		10,070
International		362		600		-		867		1,829
	$	19,879	$	3,482	$	3,179	$	4,099	$	30,639

2022 Sales by Major Market
		Military		Space		Medical		Commercial		Total
Domestic Direct	$	10,699	$	1,148	$	3,213	$	1,403	$	16,433
Domestic Distribution		7,993		1,508		-		829		10,330
International		233		351		-		438		1,022
	$	18,895	$	3,007	$	3,213	$	2,670	$	27,785

Schedule of receivables, net, contract assets and contract liabilities


	November 30, 2023		November 30, 2022		December 1, 2021
Receivables, net	$	8,021	$	3,644	$	4,974
Contract assets	$	307	$	408	$	603
Deferred revenue	$	618	$	1,192	$	1,258

Schedule of property,plant and equipment useful lives


Buildings	15-40
Facility improvements	8-15
Machinery and equipment	5-10
Furniture and fixtures	5-8

Schedule of the basic and diluted earnings per share


	Twelve Months Ended
	November 30, 2023		November 30, 2022

Weighted average of shares, basic		2,578,315		2,578,315
Restricted stock units		31,194		-
Weighted average of shares, diluted		2,609,509		2,578,315

NOTES PAYABLE TO BANKS: (Tables)

12 Months Ended

Nov. 30, 2023

Debt Disclosure [Abstract]

Schedule of long-term debt

Schedule of long-term debt
Debt	2023		2022
Notes payable	$	15,884	$	14,938
Less unamortized debt issuance costs		136		179
Net Debt		15,748		14,759
Less—Current portion		432		224
Total long-term debt	$	15,316	$	14,535

Estimated maturities of long-term debt

Estimated maturities of long-term debt
	2024		2025		2026		2027		2028		Thereafter		Total
Frost Bank	$	432	$	447	$	463	$	478	$	495	$	13,569	$	15,884

PRODUCT WARRANTIES: (Tables)

12 Months Ended

Nov. 30, 2023

Guarantees and Product Warranties [Abstract]

Schedule of product warranty activity

Schedule of product warranty activity
	2023			2022
Beginning balance	$	25		$	25
Additions for current year provision		56			114
Payments for current year		(56	)		(114	)
Ending balance	$	25		$	25

INCOME TAXES: (Tables)

12 Months Ended

Nov. 30, 2023

Income Tax Disclosure [Abstract]

Schedule of income tax provision

Schedule of income tax provision
	2023			2022
Current Provision:
Federal	$	514		$	744
State		69			70
		583			814
Deferred federal tax benefit		(389	)		(102	)
Total	$	194		$	712

Schedule of effective income tax rate reconciliation


	2023			2022
Tax at statutory rate	$	177		$	734
State income taxes, net of federal benefit		54			55
Research and Development Tax Credit		(116	)		(156	)
Permanent differences and other		79			79

Income tax provision	$	194		$	712

Schedule of components of deferred tax assets and liabilities


	2023			2022
Deferred tax assets (liabilities)
Inventory	$	330		$	265
Capitalized research and development		420			-
Deferred revenue, sales returns and warranty		5			5
Other accrued liabilities		100			83
Depreciation		(380	)		(267	)
Net deferred tax assets	$	475		$	86

STOCK-BASED COMPENSATION: (Tables)

12 Months Ended

Nov. 30, 2023

Stock-based Compensation

Schedule of restricted stock units activity


	2023				2022
(shares in thousands)	Number		Weighted-		Number		Weighted-
	of		Average		of		Average
	Shares		Grant Date Fair Value		Shares		Grant Date Fair Value

Unvested at beginning of the year		-		-		-		-
Granted		35.7	$	13.13		-		-
Vested		-		-		-		-
Cancelled		4.5	$	13.13		-		-
Unvested at end of the year		31.2	$	13.13		-		-

Schedule of stock-based compensation

Schedule of stock-based compensation
For the years ended
November 30, 2023 and November 30, 2022
	2023		2022
Stock-based compensation expense	$	98		-

Schedule of stock-based unvested compensation expense


	2024		2025		Total
Stock-based unvested compensation expense	$	156	$	156	$	312

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Product Information [Line Items]
Total Revenue	$ 30,639	$ 27,785
Transferred at Point in Time [Member]
Product Information [Line Items]
Total Revenue	27,069	23,678
Transferred over Time [Member]
Product Information [Line Items]
Total Revenue	3,570	4,107
Microelectronics [Member]
Product Information [Line Items]
Total Revenue	8,855	7,998
Optoelectronics [Member]
Product Information [Line Items]
Total Revenue	8,265	7,913
Sensorsand Displays [Member]
Product Information [Line Items]
Total Revenue	$ 13,519	$ 11,874

SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Domestic Direct	$ 18,740	$ 16,433
Domestic Distribution	10,070	10,330
International	1,829	1,022
Revenue	30,639	27,785
Military [Member]
Domestic Direct	11,937	10,699
Domestic Distribution	7,580	7,993
International	362	233
Revenue	19,879	18,895
Space [Member]
Domestic Direct	1,525	1,148
Domestic Distribution	1,357	1,508
International	600	351
Revenue	3,482	3,007
Medical [Member]
Domestic Direct	3,179	3,213
Domestic Distribution
International
Revenue	3,179	3,213
Commercial [Member]
Domestic Direct	2,099	1,403
Domestic Distribution	1,133	829
International	867	438
Revenue	$ 4,099	$ 2,670

SIGNIFICANT ACCOUNTING POLICIES (Details 2) - USD ($) $ in Thousands	Nov. 30, 2023	Nov. 30, 2022	Dec. 02, 2021
Accounting Policies [Abstract]
Receivables, net	$ 8,021	$ 3,644	$ 4,974
Contract assets	307	408	603
Deferred Revenue	$ 618	$ 1,192	$ 1,258

SIGNIFICANT ACCOUNTING POLICIES (Details 3)	Nov. 30, 2023
Minimum [Member] \| Building [Member]
Property, Plant and Equipment [Line Items]
Furniture and fixtures	15 years
Minimum [Member] \| Facility Improvements [Member]
Property, Plant and Equipment [Line Items]
Furniture and fixtures	8 years
Minimum [Member] \| Machinery Equipment [Member]
Property, Plant and Equipment [Line Items]
Furniture and fixtures	5 years
Minimum [Member] \| Furniture Fixtures [Member]
Property, Plant and Equipment [Line Items]
Furniture and fixtures	5 years
Maximum [Member] \| Building [Member]
Property, Plant and Equipment [Line Items]
Furniture and fixtures	40 years
Maximum [Member] \| Facility Improvements [Member]
Property, Plant and Equipment [Line Items]
Furniture and fixtures	15 years
Maximum [Member] \| Machinery Equipment [Member]
Property, Plant and Equipment [Line Items]
Furniture and fixtures	10 years
Maximum [Member] \| Furniture Fixtures [Member]
Property, Plant and Equipment [Line Items]
Furniture and fixtures	8 years

SIGNIFICANT ACCOUNTING POLICIES (Details 4) - shares	12 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Details 4) - shares	Nov. 30, 2023	Nov. 30, 2022
Accounting Policies [Abstract]
Weighted average of shares, basic	2,578,315	2,578,315
Restricted stock units	31,194
Weighted average of shares, diluted	2,609,509	2,578,315

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: (Details Narrative) - USD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Accounting Policies [Abstract]
Deferred Revenue recognized	$ 1,169,000
Uncertain tax positions	$ 0	$ 0

FAIR VALUE MEASUREMENT: (Details Narrative) - USD ($)	Nov. 30, 2023	Nov. 30, 2022
Fair Value Disclosures [Abstract]
Fair value financial assets liabilities recurring basis	$ 0	$ 0
Fair value non financial assets non recurring basis	$ 0	$ 0

COMMITMENTS (Details) - USD ($) $ in Thousands	Nov. 30, 2023	Nov. 30, 2022
Debt Disclosure [Abstract]
Notes payable	$ 15,884	$ 14,938
Less unamortized debt issuance costs	136	179
Net Debt	15,748	14,759
Less—Current portion	432	224
Total long-term debt	$ 15,316	$ 14,535

COMMITMENTS (Details 1) $ in Thousands	Nov. 30, 2023 USD ($)
Debt Disclosure [Abstract]
2024	$ 432
2025	447
2026	463
2027	478
2028	495
Thereafter	13,569
Total	$ 15,884

NOTES PAYABLE TO BANKS: (Details Narrative) - USD ($)	Nov. 30, 2023	May 16, 2023	Nov. 30, 2022	Mar. 26, 2021
Line of Credit Facility [Line Items]
Notes Payable	$ 15,884,000		$ 14,938,000
Construction Loan [Member]
Line of Credit Facility [Line Items]
Notes Payable	$ 16,160,000
Revolving Loan [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 6,000,000
Maximum Interest Rate		3.25%
Construction Loan Agreement [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity				$ 16,160,000
Maximum Interest Rate				3.40%

PRODUCT WARRANTIES (Details) - USD ($) $ in Thousands	12 Months Ended
PRODUCT WARRANTIES (Details) - USD ($) $ in Thousands	Nov. 30, 2023	Nov. 30, 2022
Guarantees and Product Warranties [Abstract]
Beginning balance	$ 25	$ 25
Additions for current year provision	56	114
Payments for current year	(56)	(114)
Ending balance	$ 25	$ 25

PRODUCT WARRANTIES: (Details Narrative) - USD ($)	12 Months Ended
PRODUCT WARRANTIES: (Details Narrative) - USD ($)	Nov. 30, 2023	Nov. 30, 2022
Guarantees and Product Warranties [Abstract]
Product Warranty Expense	$ 56,000	$ 114,000

LEASE COMMITMENTS: (Details Narrative) - USD ($)	12 Months Ended
LEASE COMMITMENTS: (Details Narrative) - USD ($)	Nov. 30, 2023	Nov. 30, 2022	Feb. 27, 2021
Commitments and Contingencies Disclosure [Abstract]
Operating lease, right-of-use asset		$ 14,000	$ 165,000
Operating lease liabilities			$ 165,000
Operating lease expense	$ 14,000	$ 55,000
Borrowing rate	3.25%

EMPLOYEE BENEFITS: (Details Narrative) - USD ($)	12 Months Ended
EMPLOYEE BENEFITS: (Details Narrative) - USD ($)	Nov. 30, 2023	Nov. 30, 2022
Retirement Benefits [Abstract]
Percentage of employee contributions to the plan are matched by the company at the amounts of the participants salary	6.00%	6.00%
Accrued employee benefits, current	$ 500,000	$ 476,000
Employees become vested in company contributions after two years	20.00%	20.00%

INCOME TAXES (Details) - USD ($) $ in Thousands	12 Months Ended
INCOME TAXES (Details) - USD ($) $ in Thousands	Nov. 30, 2023	Nov. 30, 2022
Income Tax Disclosure [Abstract]
Federal	$ 514	$ 744
State	69	70
Current Provision	583	814
Deferred federal tax benefit	(389)	(102)
Total	$ 194	$ 712

INCOME TAXES (Details 1) - USD ($) $ in Thousands	12 Months Ended
INCOME TAXES (Details 1) - USD ($) $ in Thousands	Nov. 30, 2023	Nov. 30, 2022
Income Tax Disclosure [Abstract]
Tax at statutory rate	$ 177	$ 734
State income taxes, net of federal benefit	54	55
Research and Development Tax Credit	(116)	(156)
Permanent differences and other	79	79
Total tax expense provision	$ 194	$ 712

INCOME TAXES (Details 2) - USD ($) $ in Thousands	Nov. 30, 2023	Nov. 30, 2022
Deferred tax assets (liabilities)
Inventory	$ 330	$ 265
Capitalized research and development	420
Deferred revenue, sales returns and warranty	5	5
Other accrued liabilities	100	83
Depreciation	(380)	(267)
Net deferred tax assets	$ 475	$ 86

INCOME TAXES: (Details Narrative) - USD ($)	Nov. 30, 2023	Nov. 30, 2022
Income Tax Disclosure [Abstract]
Uncertain tax positions	$ 0	$ 0

SIGNIFICANT CUSTOMER INFORMATION (Details Narrative)	12 Months Ended
SIGNIFICANT CUSTOMER INFORMATION (Details Narrative)	Nov. 30, 2023	Nov. 30, 2022
Product Information [Line Items]
Sale To Government	74.00%	77.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| First Customer [Member]
Product Information [Line Items]
Concentration Risk, Percentage	14.00%	18.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Second Customer [Member]
Product Information [Line Items]
Concentration Risk, Percentage	10.00%	10.00%

SHAREHOLDERS’ EQUITY: (Details Narrative) - $ / shares	12 Months Ended
SHAREHOLDERS’ EQUITY: (Details Narrative) - $ / shares	Nov. 30, 2023	Nov. 30, 2022
Equity [Abstract]
Dividends payable, date declared	Dec. 07, 2022	Dec. 07, 2021
Common stock, dividends, per share, cash paid	$ 0.10	$ 0.10
Dividends payable, date of record	Jan. 11, 2023	Jan. 11, 2022
Dividends payable, date to be paid	Feb. 10, 2023	Feb. 10, 2022

STOCK-BASED COMPENSATION (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares outstanding at beginning of period
Weighted average grant date fair value beginning of period
Number of shares granted	35.7
Weighted average grant date fair value granted	$ 13.13
Number of shares vested
Weighted average grant date fair value vested
Number of shares cancelled	4.5
Weighted average grant date fair value cancelled	$ 13.13
Number of shares outstanding at end of the period	31.2
Weighted average grant date fair value end of the period	$ 13.13

STOCK-BASED COMPENSATION (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Stock-based Compensation
Stock-based compensation expense	$ 98

STOCK-BASED COMPENSATION (Details 2) $ in Thousands	Nov. 30, 2023 USD ($)
Stock-based Compensation
Stock-based unvested compensation expense for 2024	$ 156
Stock-based unvested compensation expense for 2025	156
Stock-based unvested compensation expense	$ 312

EMPLOYEE RETENTION CREDIT UNDER THE CARES ACT (Details Narrative)	3 Months Ended
	Feb. 28, 2021 USD ($)
Employee Retention Credit Under Cares Act
Employee retention credits	$ 920,000

SUBSEQUENT EVENTS: (Details Narrative) - $ / shares		12 Months Ended
SUBSEQUENT EVENTS: (Details Narrative) - $ / shares	Dec. 05, 2023	Nov. 30, 2023	Nov. 30, 2022
Subsequent Event [Line Items]
Dividends payable, date declared		Dec. 07, 2022	Dec. 07, 2021
Common stock, dividends, per share, cash paid		$ 0.10	$ 0.10
Dividends payable, date of record		Jan. 11, 2023	Jan. 11, 2022
Dividends payable, date to be paid		Feb. 10, 2023	Feb. 10, 2022
Subsequent Event [Member]
Subsequent Event [Line Items]
Dividends payable, date declared	Dec. 05, 2023
Common stock, dividends, per share, cash paid	$ 0.10
Dividends payable, date of record	Jan. 10, 2024
Dividends payable, date to be paid	Feb. 09, 2024